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Metabolic engineering of isoprenoid biosynthesis  
in Synechococcus elongatus PCC 7942 
 
Zachary D. Wiltshire 
 
 
The feasibility of increasing isoprenoid biosynthesis in the obligate photoautotrophic 
cyanobacterium Synechococcus elongatus PCC 7942 was explored through the use of a 
heterologous mevalonate pathway. Incorporation of heterologous genes that produce non-native 
metabolic intermediates has previously been demonstrated as a method of increasing product 
formation while bypassing endogenous regulatory mechanisms. While this design strategy has 
been exhaustively explored in model heterotrophic microbes, far less work has been carried out 
in photoautotrophs. Practically, this disparity is due to the preference of using faster growing 
heterotrophs, greater understanding of metabolic regulation in model heterotrophs, and more 
limited characterisation of genes and genetic regulatory elements in cyanobacterial hosts 
(particularly S. elongatus). Here the host response to incorporation of a heterologous mevalonate 
pathway under the control of non-native promoters is characterised. Analysis was focused on 
metabolic intermediates, endogenous isoprenoid products, and cell growth indicators, primarily 
using HPLC and GC-MS. The heterologous route for isoprenoid biosynthesis was found to be 
functional. An intermediate in this pathway, mevalonate, accumulated to 70µM under standard 
laboratory conditions. Recorded changes to endogenous isoprenoid products were smaller, but 
still apparent. Because of commercial interest in phototrophic production of isoprenoids, 
particularly for fuels, I also attempted to generate a previously demonstrated biofilm phenotype 
in S. elongatus. This phenotype is of interest for testing in evanescent field based 
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Goal and Objectives 
This work aims to explore metabolic engineering of the cyanobacterium Synechococcus 
elongatus PCC 7942 (S. elongatus) for increased isoprenoid production. Isoprenoids are a 
diverse class of molecules with many uses including fuel, fragrances, health products, and as 
flexible chemical building blocks for synthetic products. S. elongatus is photoautotrophic, 
enabling direct-from-CO2 (photosynthetically-fixed carbon based) production of these 
molecules. 
Currently, many of these isoprenoids are derived from expensive plant sources or 
environmentally damaging petroleum products. Carrying out photofermentation of engineered 
microbes has the potential to increase product yield, decrease losses to side product formation, 
and sequester the atmospheric greenhouse gas, carbon dioxide. 
Production of desired isoprenoids can be improved by manipulating the host cell's 
metabolism. Two distinct metabolic pathways can carry out isoprenoid biosynthesis. One of 
these pathways is found natively in S. elongatus. I introduced the non-native version of this 
pathway in two parts into S. elongatus and examined the resulting metabolic changes to the host. 
The changes examined included metabolism of both native and foreign metabolites, as well as 
metabolic burden resulting from added genes. 
Improvements to molecule production in photoautotrophic microbes like S. elongatus can be 
sometimes negated by poor industrial photobioreactor design, particularly for low cost products 
like fuels. To complement the metabolic engineering carried out, I briefly explored biological 
design considerations for the growth of S. elongatus in higher efficiency evanescent field based 
bioreactors. 
Taken together, improvements in metabolic efficiency and growth at production scales have 
the potential to enable economically efficient synthesis of commodity and specialty chemicals 





Metabolic engineering, and the related field of synthetic biology, are quickly becoming a 
major contributor to industrial chemical synthesis. It has been estimated that biologically 
produced chemicals will compose 10% of global chemical production by the year 2020.1 Even 
without considering petroleum fuels, nearly 90 million metric tons of organic chemicals and 
lubricants are produced annually in the United States.2 Bioproducts can enter this market as 
ready-to-use chemicals, platform molecules for further synthesis, functional biopolymers, and 
mixed pools of biomolecules for processing into functional products.3 
Metabolic engineering, often using synthetic biology tools, is the cellular design process that 
is creating economically viable systems for producing these bioproducts. Early metabolic 
engineering efforts relied on slow and inadequate tools for rapid prototyping and, limited data on 
how genes and genetic regulatory elements behave in different contexts (host cell, plasmid, 
expression system). It is these problems that synthetic biology is attempting to remedy.4 
Synthetic biology has developed into such a wide umbrella term for fields inside biological 
engineering that these names are often used interchangeably. At their core, these fields are 
working to introduce engineering rigour into biology that early “genetic engineering” only 
provided in name. New tools, particularly for DNA assembly, have increased the speed of the 
engineering design-build-test cycle in biology. Synthetic biology has yielded significantly more 
complex systems than its predecessor through the characterisation of genes and genetic 
regulatory elements, and the creation of novel (or rebuilt) biological systems, giving clearer 
insight into design guidelines for biological networks. As synthetic biology provides new tools 
and knowledge, metabolic engineering will continue to benefit.  
Metabolic engineering's major focuses are improving existing metabolic systems (for a 
desired metabolite) and the creation of metabolism that does not exist in the cell being 
engineered.5 Examples include biosynthesis of molecular precursors for therapeutics in bacteria 
and yeast, manufacture of polymer feedstocks, and microbial production of jet fuel.6–9  
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While not limited to microbial species, this is where a large majority of work has been 
carried out. Non-microbial targets are typically agricultural plants, which can be similarly grown 
on large scales.10  
Economics, biology, and engineering of biofuels  
Photosynthetic microorganisms have not seen the same widespread industrial adoption as 
obligate heterotrophs fed plant biomass for biofuel production. This has been partially due to 
historical industrial organisms (such as Saccharomyces cerevisiae - brewing yeast) having 
greater existing infrastructure, and because of the lower entry barrier for obtaining an 
economically viable strain.  
S. cerevisiae strains naturally demonstrate significant ethanol production ability and 
tolerance to the ethanol produced. This trait is regularly employed at the largest industrial 
fermentation scales in the world for the production of fermented beverages, particularly beer. 
While there are significant markets and distribution infrastructure for ethanol-containing 
beverages, ethanol biofuels have been mainly limited to major distribution in Brazil and in 
blends with traditional gasoline elsewhere. Ethanol biofuel production in Brazil is strongly 
incentivised by the high availability of sugarcane to use as a feedstock in heterotrophic 
fermentation. In the United States, economic viability of traditional heterotrophs has been 
artificially increased through the use of feedstock subsidies, particularly corn, in order to produce 
"greener" fuels. These subsidies have in some cases resulted in higher food costs and a decrease 
in the proportion of agricultural land use for food production.11 Use of agricultural wastes (by 
themselves or from dedicated fuel crops,) that are high in lignocellulosic materials, will help 
decrease fermentation wastes and feedstock costs, and "green" the biofuel fermentation process 





Because heterotrophic biofuels are generated by organisms consuming biomass generated by 
photosynthetic organisms, significant energy loss occurs in the transition from sunlight to fuel. 
Using a photosynthetic microbe (ie. a photosynthetic microalgaeA) directly for the production of 
biofuels eliminates this second biomass generation step, and decreases the associated carbon 
emissions in the fuel generation process. 
Algae can be used for biofuel generation in three main ways, with each method having been 
demonstrated at pilot or production scale:  
 Growth as an alternative "crop" to feed heterotroph fermentation as described 
above.12  
 Whole cell conversion by pyrolysis to "biocrude".13,14 
 Secretion or accumulation of biofuel or biofuel precursor chemicals generated by 
engineering the algae's metabolism.15 
When used as feedstock, cultivated microalgae reduces the complexity involved in using the 
total photosynthetic biomass. Unlike plants, the carbon-rich, degradation-resistant structural 
polymers lignin and cellulose are not found in microbial algae.16  
The biocrude approach can readily use natural or engineered algae. These algae are typically 
highly lipid-rich eukaryotes. In this approach, more than 50% of dry cell weight can be 
converted into biocrude, and substantial amounts of nitrogen is left behind that can be processed 
for use in fertiliser.17 In some cases, the environmental benefits of using a photosynthetic 
organism are lost because product yields may be substantially better when eukaryotic algae are 
fed heterotrophically. In an example using the mixotrophic green algae Chlorella protothecoides, 
                                                          
A  Algae being a polyphyletic group consisting of organisms containing a photosynthetic apparatus (or 
ancestrally containing a functional plastid,) while lacking the structural features that characterise land plants. 
Organisms in this group include cyanobacteria, archaeplastidans (rhodophyta, chloroplastida/viridiplantae, 
glaucophyta), and a subset of the remaining Bikonts that underwent secondary endosymbiotic events. To distinguish 
single and multicellular algae, single celled species are often referred to as microalgae.136 
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when fed heterotrophically, lipid accumulation was nearly four times greater than during 
photoautotrophic growth.18   
Production and secretion of liquid biofuels generally involve metabolic engineering to 
generate sufficient fuel yields. In some cases, natural metabolic process, such as those designed 
to combat environmental stress, can augment yields by helping redirect carbon flux.19,20  
Examples include ethanol secretion by Synechococcus elongatus PCC 7942 (S. elongatus) and 
free fatty acid generation by Synechocystis sp. PCC 6803.21,22 Generally, secretion is preferred 
over accumulation because of decreased recovery and purification costs. When lipids are the 
target molecule, an accumulation approach can result in 30% of production costs going towards 
purification.23 
Current limitations to photosynthetic approaches 
The main drawbacks to using photosynthesis, rather than heterotrophic systems, include 
slower growth rates, more expensive/inefficient infrastructure required for large scale production 
facilities, and structural inefficiencies in the photosynthetic process such as energetic waste due 
to chlorophyll antenna size.24 
Heterotrophic microbes display very rapid growth when nutrients are not limiting in their 
environment. Under optimal conditions, common laboratory Escherichia coli strains have 
doubling times of approximately eighteen minutes.25 Saccharomyces cerevisiae are roughly 5.5 
times slower at 100 minutes per optimal doubling.26 Reported growth rates for common 
photosynthetic organisms are significantly slower still. S. elongatus has a typical doubling time 
of approximately 420 minutes.27 Under heavily optimized conditions, the doubling time may be 
as low as 246 minutes.28 A model eukaryotic algae, Chlorella pyrenoidosa doubles every 11 
hours when grown photoautotrophically.29 Dunaliella sp., investigated for carotenoid production, 
have recorded doubling rates of 15-20 hours.30,31 Recently, Synechococcus UTEX 2973, a close 
relative of Synechococcus elongatus PCC 7942, was described by Yu et al. as having an 
optimised doubling time of only 114 minutes under autotrophic conditions.28  
Growing algae under phototrophic conditions necessitates each cell have access to light. 
Raceway style ponds are the traditional growth system for microalgae, having been used for the 
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past 60 years.32 They provide an inexpensive (depending on land cost,) low complexity growth 
system. Raceway pond efficiency as a bioreactor is directly proportional to their physical area 
and local climate. The density of the microalgal culture is limited by the ability of the raceway 
design to efficiently mix the culture and, the ability for light to penetrate into the culture.33 
Contamination is often cited as a concern with this type of open reactor design, but raceway 
designs remain one of the systems of choice for non-transgenic microalgae such as Arthrospira 
spp. (Spirulina) because of their ease of implementation.34 Because raceway systems are an open 
reactor design, environmental biodiversity concerns are raised when transgenic algae are used. 
These concerns have lead some algal fuel companies to pursue the development of suicide 
systems for their strains that limit strain viability outside of their reactor systems.35   
Closed reactor systems exist in a variety of formats, but are generally composed of 
interconnected tubing or panels that increase the photosynthetically productive surface area of 
the system. Further efficiency gains can be realised through the increased environmental control 
available in closed systems. However, these productivity increases come at a financial cost. The 
physical infrastructure of closed systems is more expensive than open ponds. Traditional 
fermentation tanks are generally not considered a viable option for scaled photosynthetic growth 
because of their very low surface area to volume ratio.  
The economic viability of photobiofuels will benefit the most from new photobioreactor 
designs that increase cell density while maintaining light availability. One of the more novel 
approaches to this photobioreactor problem has been the use of waveguides designed for the 
efficient distribution of light to algal monolayers. In a traditional photobioreactor the surface 
tends to be too bright and the interior too dark, resulting in only a small percentage of the reactor 
volume maintaining optimal growth conditions. Using the evanescent field generated by 
waveguides to grow algal monolayers promises order-of-magnitude improvements in the 
proportion of maximally productive algae in the reactor. These productivity increases will be 
most notable where cyanobacteria are employed, due to their size. Their diameter corresponds to 
the 1µm optimal penetration depth of the evanescent field beyond the waveguide.36 Eukaryotic 
algae can have a diameter ten times larger than this.37,38  
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Alongside improved growth regimes for photosynthetic microbes, improvements to 
photosynthesis may greatly improve photobiofuel economic viability. Significant energy loss 
occurs at every conversion step in oxygenic photosynthesis. Less than half of the incident 
sunlight is absorbed, and at most two-thirds of that absorbed energy can be converted to 
chemical energy in the photosystems.24 Further energy loss occurs at the point of molecular 
hydrogen generation. When energy loss due to metabolism for biomass accumulation is factored 
in, the highest possible total energy conversion efficiency from sunlight is only 10%.24 When 
cells are placed in light conditions that exceed the system's photosynthetic ability, mechanisms 
such as non-photochemical quenching are employed to limit over-production of damaging 
reactive oxygen species. These type of issues are beginning to be addressed by improvements to 
light harvesting antenna, increased diversity of functional pigments, and enzyme/metabolism 
efficiency improvments.24 
To investigate and improve metabolic inefficiencies in photosynthetic microbes, 
cyanobacteria have proven to be one of the best test systems. This is due to their simpler cellular 
organisation, earlier fully sequenced genomes, and the better stability of transformed strains.39 
Coupled with improved techniques for metabolic engineering, these reasons have resulted in a 
larger body of work of molecular studies applicable to metabolic engineering work. 
Metabolic engineering in cyanobacteria 
Only within the last decade have cyanobacteria become a production platform for metabolites 
outside their natural biochemistry. Endogenous metabolites targeted include biohydrogen and the 
carotenoids (Table 1).40–43 Outside of this rudimentary biotechnological use of cyanobacteria, 
major studies with cyanobacteria have focused on ecological aspects, photosynthesis, and 
chronobiology.44 
S. elongatus has been particularly important in moving chronobiology forward by allowing 
for more robust, large scale studies. Prior to the introduction of S. elongatus, generation of 
circadian clock mutants in various eukaryotes was haphazard and was coupled with a poor 
understanding of the underlying genetics.45 While not evolutionarily related to the eukaryotic 
circadian clocks, the S. elongatus kaiABC system provided a simpler regulatory network that 
could be easily manipulated. Studies of kaiABC have supplied an excellent understanding of 
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oscillatory genetic circuit dynamics. The promoters related to this circuit have also been widely 
used historically for expression of genes in this and related species.46 
S. elongatus and similarly named (but not directly related) freshwater cyanobacteria have 
become the focus of engineering efforts for a variety of commodity chemicals including 
endogenous chemicals, sugars,47,48 other hydrophilic compounds,49,48,50 and a wide variety of 
fuels (Table 1). 
Carotenoids 
Carotenoid production in algae has been investigated for decades (Table 1).41–43,51 These 
endogenous compounds are of particular interest for the health food/supplement industry. Under 
certain stress conditions, particular natural algal strains have been measured to produce extreme 
quantities of carotenoids. β-carotene levels in Dunaliella salina were measured in one study to 
compose 40% of the culture's dry cell weight (DCW).41 Although subsequent studies have not 
reported such high yields in Dunaliella sp., DCW yields between 3-10% have been 
reproduced.42,51 However, it must be kept in mind that these yields generated in highly controlled 
systems are order(s) of magnitude higher than those reported at production scale.51  
Hydrophilic commodity chemicals 
Glucose 
These hydrophobic endogenous chemicals provided an obvious starting point for the 
biotechnological use of algae (Table 1). The use of stress regimes has also allowed for the 
exploitation of underlying metabolic processes involving hydrophilic compounds. In 
Synechococcus spp., osmotic stress induced by high salt concentrations was shown to be 
managed by the production of sucrose as an osmolyte.52–54 Utilising this natural metabolic 
process, Niederholtmeyer et al. (2010) converted S. elongatus into a sugar secreting microbial 
factory.48 Their system involves enzymatic cleavage of the sucrose osmolyte into glucose and 
fructose, followed by facilitated diffusion out of the cell. This type of system contrasts directly 
with heterotrophic fermentation systems that require a reduced carbon (often sugar) input. The 
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use of the sugar secreting strain has been shown to support co-cultures at laboratory scale, and 
has even been proposed for use with artificial chloroplast/endosymbiotic systems.48,55  
One reported problem with this system was a plateau reached in sugar concentration. Further 
investigation by the authors suggested this was due to biochemical and metabolic limitations 
inherent in the system as presented. The hexose sugar transporter employed was bidirectional 
and passive and, S. elongatus was only able to produce sucrose during the light phase of its 
diurnal cycle, likely consuming the hexose sugars during the dark phase.48 
Sucrose 
A similar study was carried out where S. elongatus was engineered to excrete sucrose 
directly. Yields were substantially higher with a final estimated titre of 2.6 g/L at a consistent 
rate of 36.1 mg/L/h. In a variety of the better environmental conditions reported in the study, 
sucrose production represented at least 40% of the biomass generated.20 
Lactate 
With another hydrophilic compound in S. elongatus, lactate, this concentration plateau was 
not observed, likely due to the secretion transporter chosen.48 The lactate transporter, LldP, 
transports lactate using coupled transport driven by a proton gradient. During normal growth, S. 
elongatus can easily alkalise its growth medium to above pH 9, creating a proton gradient that 
can consistently export lactate. Lactate concentrations observed were roughly 2.5 times greater 
than the hexose sugars (Table 1). A similar engineering experiment in Synechocystis sp. PCC 
6803, which did not include transporters, yielded lactate concentrations 3.2 mM (5x more than in 
S. elongatus.)50   
Biofuels and polymers 
Fuel production continues to be the most researched area for metabolic engineering in algae. 
For this reason, only examples in cyanobacteria will be discussed at length. This research boom 
has been driven by the need to generate energy production systems that can be used regionally 
for energy security and, to reduce the "carbon footprint" associated with the energy generation. 
The majority (but not all) have been chosen for their ability to function as "drop-in" fuels that do 
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not require modifications to the existing liquid fuel distribution and consumption systems. 
Criteria for being considered a drop-in fuel typically consist of having octane/cetane numbers 
similar to existing gasoline or diesel, the ability to blend with petroleum fuels over a wide range 
of concentrations, very limited hygroscopicity, and similar viscosity/gelling properties.56 
Since many of these biofuels have chemical structures similar to the petroleum products they 
are designed to replace, they may also be utilised for processes beyond combustion just as 
petroleum products are. One of the most economically relevant of these uses is as precursor 
material for structural polymer synthesis. Example use cases include ethylene for the common 
thermoplastic polyethylene and isoprene for synthetic rubber. 
Ethylene 
Three well-studied enzymatic systems can facilitate ethylene biosynthesis, with two of these 
having been added to cyanobacterial hosts. The first, found in higher plants, is a two-enzyme 
process that uses 1-aminocyclopropane-1-carboxylic acid (ACC) synthase and ACC oxidase 
(ACS-ACO.) Ethylene synthesis through this route is dependent on methionine availability. 
These enzymes have been used in Synechocystis sp. PCC 6803 without any additional 
engineering, generating poor yields (10nl/ml/h/OD750) (Table 1).
57 
The second pathway is bacterial and also methionine dependent. However, instead of 
proceeding through s-adenosylmethionine like ACS-ACO, 2-keto-4-methyl-thiobutyric acid 
(KMBA) is used.58 Use of the bacterial KMBA enzymes have not yet been explored in 
cyanobacteria. 
The third route, found in some bacterial plant pathogens (eg. Pseudomonas syringae,) is 
composed of a single enzyme, "ethylene forming enzyme" (EFE). EFE requires 2-oxoglutarate 
(2-OG), arginine, and dioxygen. This 2-OG dependent route is currently the most explored 
method for ethylene biosynthesis, particularly in cyanobacteria. Until recently, all ethylene work 
in cyanobacteria had focused only on the EFE (or ACS-ACO) enzyme(s) and environmental 
conditions. Productivity of EFE expressing strains could not be maintained beyond a few 
passages of the culture. Ungerer et al. improved the stability of EFE expression in Synechocystis 
sp. PCC 6803, leading to multiple order-of-magnitude yield improvements.59 Further metabolic 
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engineering, focused particularly around 2-OG in the tricarboxylic acid cycle, has provided an 
additional 1.5-fold improvement to ethylene yield. At 7514μl/l/h, this represents >7% of the total 
carbon fixed by the cell. 
Ethanol 
While engineering for ethanol has been long carried out in heterotrophic microbes, 
particularly S. cerevisiae, work in algae for ethanol production began in 1999 (Table 1). Deng 
and Coleman's seminal paper entitled "Ethanol synthesis by genetic engineering in 
cyanobacteria" expanded the field of rational metabolic engineering for exogenous metabolites 
into the use of cyanobacteria.21 Using a two-gene operon containing pyruvate decarboxylase and 
alcohol dehydrogenase II from Zymomonas mobilis they demonstrated total ethanol 
accumulation of up to 1.71mM by S. elongatus. Production was recorded with both the 
endogenous rbcLS and E. coli PLAC promoters. 
Butanol 
Isobutyraldehyde is a biological precursor isobutanol production and other petroleum derived 
commodity chemicals. Atsumi et al. introduced genes for increased valine biosynthesis to S. 
elongatus to enable high level production of isobutyraldehyde.60 Their maximum production of 
723mg/l was higher than all similar systems in S. elongatus at the time of publication. When 
genes for isobutanol production were added, yield dropped to approximately 60% of the 
precursor total. These yields were shown to be related concentration limits for product toxicity in 
the host. 2-methyl-1-butanol was later demonstrated by similar means, using isoleucine 
biosynthesis for precursor production. Total yield only reached 200mg/l, with 2-methyl-1-
butanol biosynthesis resulting in a lower toxicity threshold (Table 1).61 
Fatty acids and alkanes 
Continuous free fatty acid biosynthesis presents a challenge because of the need to decouple 
production from cell growth. Natural cyanobacteria with the highest lipid accumulation are 
typically under environmental stress, with a correspondingly slow growth rate. The most 
effective free fatty acid engineering in cyanobacteria has so far followed a similar methodology 
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to that used in E. coli (Table 1). The introduction of an acyl-acyl carrier protein (ACP) 
thioesterase (ACP-TE) converts an acyl-ACP molecule to the corresponding fatty acid.  
In Synechocystis sp. PCC 6803, an E. coli ACP-TE was added along with modifications to 
weaken the cell wall, and knockouts to reduce diversion of carbon to side products. One of these 
knockouts eliminated diversion of acetyl-CoA to acetyl phosphate. Acetyl phosphate has been 
suggested to function as a global genetic response regulator in Synechocystis sp. PCC 6803.62 
Yields of secreted free fatty acids in this system (primarily C12/C14/C16) were as high as 197 
mg/l.22  
Targeted production of alkanes from fatty acid metabolism has been reported as high as 26 
mg/l in Synechocystis sp. PCC 6803.63 The dedicated enzymes taking fatty aldehydes to alkanes 
and alkenes were overexpressed and, enzymes diverting carbon away from fatty acid metabolism 
were knocked out. Newer single cell screening techniques for fatty acid/alkane production in 
cyanobacteria promise to increase the speed that new strains can be analysed.64 
Isoprenoids and terpenoids 
Lindberg et al. (2010) provided the first demonstration of metabolic engineering for 
isoprenoid fuels in cyanobacteria (Table 1). Using Synechocystis sp. PCC 6803, the authors 
introduced only an isoprene synthase and demonstrated isoprene production.65 In a later study 
focused on bioreactor design using the same strain, the authors calculated that maximally 0.08% 
of fixed carbon was being partitioned into isoprene.66 Bentley et al. (2014) continued this work 
with the addition of a heterologous mevalonate pathway to increase isoprenoid flux. Isoprenoid 
biosynthesis is described in detail in the section that follows. Over an eight-day growth period, 





more productive than the original with only the isoprene synthase.67,B 
Limonene biosynthesis was demonstrated by Halfmann et al. (2014) in the filamentous 
cyanobacterium Anabaena sp. PCC 7120. In this study, the limonene synthase from the Sitka 
spruce was introduced into the cyanobacterium, along with genes for three rate limiting enzymes 
in the endogenous MEP isoprenoid pathway.68 Photosynthetic production of farnesene was also 
very recently demonstrated in the filamentous cyanobacterium Anabaena sp. PCC 7120. Similar 
to the original work with isoprene biosynthesis in Synechocystis sp. PCC 6803, only the single 
gene required for synthesis of the final product was introduced. The authors recorded the rate of 
farnesene synthesis as 69.1μg/l/OD700/day. Of interest in their results was a 60% increase in 
photosystem II activity when the farnesene synthase was expressed. (Photosystem II activity was 
also recorded to be higher in the limonene producing strain.) Although this filamentous, 
heterocyst-forming cyanobacterium is interesting for its ability to fix nitrogen, it is largely 
unexplored for industrial biosynthesis. 
  
                                                          
B In all three studies, the isoprene-synthase-only base strains were reported to result in the same isoprene yields 
when compared side by side.67 This conflicts with the preliminary values presented in 2010. Assuming the 2014 data 
is correct, the 2010 isoprene yields were over-reported by 3.4 times. This discrepancy may be assigned to 
differences in growth conditions; in 2014 the strains were grown in the novel photobioreactor described in their 
2012 study. Although along with improved isoprene harvesting, this reactor was designed specifically to increase the 
carbon available to the strains. 
14 
 




















Synechocystis sp. PCC 6803 
 
3 - 40% DCW 
8% DCW 





Hydrophilic commodity chemicals 
    
Glucose/fructose Synechococcus elongatus PCC 7942 250 µM (45 mg/l)   47,48 
Sucrose Synechococcus elongatus PCC 7942 (2.6 g/l) 36.1 mg/l/h   
Lactate Synechococcus elongatus PCC 7942 
Synechocystis sp. PCC 6803 
620 µM (55 mg/l)  
3200 µM 
54 mg/l/day/Abs750   48 
50 
D-mannitol Synechococcus sp. PCC 7002 (84.6 mg/l/OD730) 
1100 mg/l 
0.15 g/l/day  69 
 
Biofuels and Polymers 
    
Hydrogen Synechococcus elongatus PCC 7942   40(70) 
Ethylene Synechococcus elongatus PCC 7942 
Synechocystis sp. PCC 6803 
- 
9739 μl/l/h  (2-OG fed) 
7514 μl/l/h  (not fed) 
451 nl/ml/h/OD730 
858 µl/ml/h/OD730  (fed) 
71 (72) 
73 (57,59) 
Ethanol Synechococcus elongatus PCC 7942 




54 nmol/OD730/l/day  
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Metabolic pathways for isoprenoid precursors 
Isoprenoids and terpenoids make up a wide array of molecules that have shown promise as 
biofuels and their precursors. These secondary metabolites can be produced through two 
evolutionarily distinct metabolic pathways. These pathways are known as the mevalonate 
(MVA) pathway and the 2C-methyl-D-erythritol 4-phosphate (MEP; or 1-deoxy-D-xylulose 5-
phosphate (DOXP); or non-mevalonate) pathway (Figure 1). The MVA route is found in 
eukaryotes, archaea, and some eubacteria. The MEP genes are found in plant and algal 
chloroplasts and most eubacteria. These categorisations of where the pathways are found can 
only be considered general guidelines. Lateral gene transfer has played a significant role in the 
genes used to produce isoprenoids.79  
While both pathways have seven core enzymatic steps and result in the production of 
isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), the pathways' 
precursors differ. The MEP route uses pyruvate and glyceraldehyde-3-phosphate (G3P) and, the 
MVA route begins with acetyl-CoA. Following the MEP route, pyruvate and G3P generate 
DOXP and release one CO2 molecule via the DOXP synthase. DOXP is then taken to MEP by 
DOXP reductoisomerase (DXR). This DXR mediated reaction is NADPH dependent. A 
cytidylyltransferase then adds a cytidine phosphate group (from cytidine triphosphate - CTP) to 
MEP, forming 4-diphosphocytidyl-2-C-methylerythritol (CDP-ME) and releasing a free 
pyrophosphate. A CDP-ME kinase then adds a phophate group (from adenosine triphosphate - 
ATP) to form 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-MEP) and a free 
adenosine diphophate. CDP-MEP is then cyclised to 2-C-methyl-D-erythritol 2,4-
cyclopyrophosphate (MEcPP) by MEcPP synthase, releasing a cytidine monophosphate (CMP) 
molecule. Using two oxidised ferredoxin units, (E)-4-hydroxy-3-methyl-but-2-enyl 
pyrophosphate (HMB-PP) synthase then catalyses the reaction of MEcPP into HMB-PP. The 




Following the MVA route, two acetyl-CoA molecules are combined with a thiolase enzyme, 
forming acetoactyl-CoA. The next reaction forms 3-hydroxy-3-methylgluaryl-CoA (HMG-CoA) 
via HMG-CoA synthase. HMG-CoA is then taken to mevalonate by the NADPH-dependent 
HMG-CoA reductase. Two successive ATP-dependent phosphorylations then occur, taking 
mevalonate to mevalonate-5-phosphate and then mevalonate-5-pyrophosphate. These reactions 
are mediated by mevalonate kinase and phosphomevalonate kinase, respectively. Mevalonate-5-
pyrophosphate (MPP) then undergoes an ATP-dependent enzymatic decarboxylation, by MPP 
decarboxylase, to IPP. A bidirectional isomerase may then interconvert IPP and DMAPP.  
Further enzymatic steps may take IPP/DMAPP to longer chain isoprenoid pyrophosphates. 
All of these elongated pyrophosphates are composed of multiple isoprene (IPP/DMAPP) units 
combined in a chain. IPP and DMAPP combined by a farnesyl pyrophosphate synthase (FPPS) 
result in geranyl pyrophosphate (GPP). FPPS can then add a second IPP molecule to GPP to 
result in farnesyl pyrophosphate (FPP). A third IPP molecule may then be added to FPP by a 
geranylgeranyl pyrophosphate synthase (GGPPS) to form GGPP. These pyrophosphates are used 
as the building blocks for all isoprenoids, including carotenoids and chlorophyll precursors. The 
MVA route is commonly referenced in engineering studies as being composed of two blocks: a 
"top" or "upper" mevalonate pathway composed of the first three enzymatic steps, and a 
"bottom" or "lower" mevalonate pathway composed of the remaining steps.6 
Isoprenoid diversity 
Tens of thousands of natural isoprenoid molecules have been described.80 The chemical basis 
for all of this molecular diversity is IPP and DMAP (isoprene units), although extensive 
modification can be carried out on the base isoprenoid molecule. Isoprenoids can range from 
simple undecorated chains of isoprene units to heavily modified multi-cyclic structures that bear 







2C-methyl-D-erythritol 4-phosphate (MEP) and mevalonate (MVA) isoprenoid biosynthesis routes with relevant products shown. 
Abbreviations: G3P, glyceraldehyde 3-phosphate; DOXP, 1-deoxy-D-xylulose 5-phosphate; MEP, 2C-methyl-D-erythritol 4-phosphate; CDP-ME, 4-
diphosphocytidyl-2-C-methylerythritol; CDP-MEP, 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate; MEcPP, 2-C-methyl-D-erythritol 2,4-
cyclopyrophosphate; HMB-PP, (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate; FD, ferredoxin; IPP, isopentyl pyrophosphate; DMAP, dimethylallyl 
pyrophosphate; HMG-CoA, 3-hydroxy-3-methylgluaryl-CoA; MevP, mevalonate-5-phosphate; MPP, mevalonate-5-pyrophosphate; GPP, geranyl 
pyrophosphate; FPP, farnesyl pyrophosphate; GGPP, geranylgeranyl pyrophosphate; '__'PP-S, '__' pyrophoshate synthase; FS, farnesene synthase. 




The number of these isoprene units incorporated into the final molecule help provide a 
general naming system for the compounds. (Table 2)  Hemiterpenes (ie. isoprene), containing 
only five carbon atoms, are highly volatile and have combustion properties similar to 
components of blended jet fuel.81 Because of its simplicity and ease of purification, isoprene can 
readily be used as a chemical feedstock for producing synthetic rubber and other compounds 
typically generated from petroleum. Monoterpenes (with 10 carbon atoms,) such as limonene and 
pinene, have higher boiling points that make them suitable for use in both everyday products and 
high performance fuels. (Dimerised pinene has been demonstrated to have characteristics nearly 
identical to JP-10 tactical fuel. Petroleum based production of JP-10 is generally regarded as 
prohibitively expensive for general use).82,83 Hydrogenated sesquiterpenes (with 15 carbon 
atoms,) such as farnesane, behave similarly to petroleum diesel during combustion. Similar to 
isoprene and pinene, sesquiterpenes have value as building blocks for larger molecules in 
chemical synthesis processes.84–86  
 







Examples and Uses 
(*denotes fuel use) 
Hemi-terpene 5 1 *Isoprene (Platform chemical) 
Mono-terpene 10 2 *Limonene (Cleaning products) 
*Pinene (Perfumery) 
 Sesqui-terpene 15 3 *Farnesene (Platform chemical) 
Humulene (Medical) 
CoQ (Health supplements) 
Bacteriochlorophyll precursor 
Di-terpene 20 4 Retinal 
Taxadiene 
Bacteriochlorophyll precursor 
Chlorophyll precursor (phytol) 
Sester-terpene 25 5 (Comparatively rare in nature) 
Tri-terpene 30 6 Squalene (Cosmetics) 
Steroid precursor 
Sesquar-terpene 35 7 (Primarily microbial) 
Tetra-terpene 40 8 Carotenoids (Health supplements) 






Metabolic engineering of isoprenoids in cyanobacteria 
Work carried out for the metabolic engineering of these isoprenoids has typically involved 
increasing metabolic flux through to IPP/DMAP. In eukaryotes harbouring the MVA pathway, 
this has been accomplished through over-expression of MVA genes or expression of a 
heterologous MEP pathway. Work in prokaryotes has involved the opposite: over-expression of 
MEP genes or expression of a heterologous MVA pathway.87 
Over-expression of existing enzymes can be a useful tool in metabolic engineering. Such 
systems have traditionally been easier to construct because of the ability to PCR the relevant 
genes directly from the target organism. A serious drawback to relying on the organism's existing 
metabolism is the set of constraints imposed on any engineering designs by the cell's existing 
regulatory mechanisms. These mechanisms include transcriptional or translational effects, and 
direct regulation of the relevant enzymes. Changes induced by these mechanisms can include 
concentration dependent negative regulation and redirection of carbon flux to unwanted 
products. Using heterologous genes/enzymes can help reduce or eliminate problems associated 
with a cell's endogenous regulatory mechanisms. 
Early (and some more recent) metabolic engineering work for isoprenoids often utilised the 
coloured carotenoid tetraterpenes as a screen of metabolic flux through the MEP/MVA 
pathway.88–93 Carotenoids, (with the particular exceptions of phytoene and phytofluene which 
absorb in the ultraviolet,) range in colour from pale yellow to deep red. Including heterologous 
genes leading to a particular carotenoid allows for a quantifiable colourmetric assay of 
MEP/MVA pathway output. This type of assay is most functional in cell types with low levels of 
similarly coloured pigments.  
As mentioned earlier, metabolic engineering of cyanobacteria for isoprenoid production is 
just starting to be explored.65,67,78 Like chloroplasts and other eubacteria, cyanobacteria use the 




Increasing isoprenoid biosynthesis for farnesene production in cyanobacteria 
The work presented here explores the use of a heterologous MVA pathway in Synechococcus 
elongatus PCC 7942 (S. elongatus) for α-farnesene production. Strain design for improved use in 
evanescent light based photobioreactors is also considered. 
S. elongatus was chosen as the photosynthetic platform for exploring industrially relevant 
sesquiterpene production because of the broader knowledge of its physiology and genetics 
compared to many other microalgae. It also has a high degree of genetic tractability compared to 
other systems. Reliable transformation protocols have been demonstrated, including natural and 
conjugation based methods and, the species has a high efficiency of spontaneous, DNA 
sequence-mediated genomic recombination.94,95 Additionally, multiple genomic regions have 
been characterised ("neutral sites") that enable foreign DNA integration with limited effect on 
the host.48,96 However, a known complication to genomic integrations in S. elongatus is its 
polyploidy. The majority of cells have four or more (up to ten) copies of its chromosome at any 
given time.97 
The choice of S. elongatus was also made because of its size. This metabolic engineering 
project was designed to run concurrently with the development of novel evanescent light based 
photobioreactors. The evanescent field generated by waveguides in this type of reactor does not 
penetrate far enough for optimal use of the photosynthetic machinery in larger microbes.36,98 
Because optimal light harvesting in these systems requires a constant monolayer of 
cyanobacteria along the waveguide surface, it is preferable to maintain the bacteria adsorbed to 
the surface while flowing only media through the reactor's dysphotic/aphotic zones. To facilitate 
this monolayer, I attempted to reproduce a recently described knockout-induced biofilm 
phenotype in S. elongatus.99 The original authors describe the major cause of the phenotype as 
inactivation of homologues of the type II secretion/type IV pilus assembly, resulting in impaired 
protein secretion. This impaired secretion is hypothesised to limit the functionality of a secreted 




Materials and Methods 
Metabolic engineering strategy 
The MVA pathway components tested here were originally designed for use in E. coli to 
increase isoprenoid production.6 Gene components were primarily from S. cerevisiae, with some 
exceptions (Table 3). The original version of this pathway was noted to have problems with flux 
balances that reduced its efficiency. These imbalances (particularly HMG-CoA accumulation) 
have been addressed in multiple later publications.100–103 One of the simpler methods used to 
improve pathway balance was carried out by screening variants of the HMG-CoA reductase.103 
Variants included a NADH-preferring version from Delftia acidovorans and NADPH-preferring 
version from Staphylococcus aureus. As NADPH is the major carrier of reducing equivalents in 
photosynthetic cells, the Staphylococcus aureus HMG-CoA reductase variant was chosen to be 
examined here first.48 
Table 3. Mevalonate pathway genes used in this study 
Pathway 
Gene 







atoB Acetoacetyl-CoA thiolase Escherichia coli  6,103 
HMGS 
(EG13) 
HMG-CoA synthase Saccharomyces cerevisiae  




ERG12 Mevalonate kinase Saccharomyces cerevisiae  6 
ERG8 Phosphomevalonate kinase Saccharomyces cerevisiae  
MVD1 Mevalonate pyrophosphate 
decarboxylase 
Saccharomyces cerevisiae  
idi Isopentenyl pyrophosphate 
isomerase 
Escherichia coli  
ispA Farnesyl pyrophosphate 
synthase 
Escherichia coli  




Suitability of these pathway components for enhancing isoprenoid production in S. elongatus 
was assessed using relevant metabolites and cell growth rates. Each component block was 





Figure 2. Heterologous operons for isoprenoid production 
Genes were expressed in three separately controlled operons. The top MVA block (atoB-HMGS-HMGR) was under 
the control of a PLAC promoter. The bottom MVA block (ERG12-ERG8-MVD1-idi-ispA) also used PLAC. The 
farnesene synthase (FS) was under the control of a PLacUV5 promoter. Genes in each translational block contained 
separate ribosome binding sites for independent translation, indicated by ® marks. Species of origin for genes are 
listed in Table 3. 
 
 
Functionality of the upper and lower MVA operons were assessed both independently and 
together. Functionality of the farnesene synthase was assessed only independently in this work. 
The upper pathway and farnesene synthase were assessed by end product formation (mevalonate 
and α-farnesene, respectively.) The lower pathway was assessed by supplying mevalonate to the 
culture medium.  
While efficient substrate uptake is common for heterotrophic species, obligate 
photoautotrophs can have significantly impaired abilities to make use of fed substrates. The 
opposite has also been shown to occur, where synthesised small molecules remain trapped in the 
production host. This behaviour is linked to the loss of metabolite transporter proteins not 
required by photosynthetic hosts.48 
Effects of the complete MVA pathway were examined by looking at changes to endogenous 
metabolism. Of particular relevance for this are the tetraterpene carotenoids, which are required 
for photosynthetic light capture and reduction of oxidative damage. Chlorophyll a (with its 
phytol {a diterpene} derived side chain,) is similarly relevant. Environmental and physiological 
studies also often use chlorophyll a as an additional indicator of differences in biomass. 
Carotenoid levels have been demonstrated to be flexible and are typically varied by the cell 
to deal with changes to environmental conditions, particularly light stress. In S. elongatus, the 
major carotenoid species are β-carotene, zeaxanthin, and echinenone.105 β-carotene is the major 
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species under typical laboratory conditions.106 In this work I examine whether increased 
isoprenoid flux results in changes to this major isoprenoid species in S. elongatus. In parallel, 
changes to chlorophyll a content are monitored. In all instances, growth rates are recorded to 
assess the metabolic burden to the cell when expressing the transgenes. 
All operons tested were under the control of common chemically inducible lac promoters. 
The upper and lower MVA operons used PLAC promoters. PLacUV5 was used for the farnesene 
synthase. The lac repressor enzyme was expressed in parallel to the experimental genes, under 
the control of its own promoter. Lac promoters have had varying levels of efficacy in different 
cyanobacterial systems. In S. elongatus, they have seen limited, but effective use.40,48,107–111  
Strains and media 
Escherichia coli 
Escherichia coli (E. coli) strain DH5α was used for the construction and maintenance of 
plasmids and, assaying of α-farnesene production. For general use, E. coli was grown in pre-
sterilized Miller lysogeny broth (LB) at 37°C. For selection of E. coli on solid media, LB was 
mixed with 1.5% (w/v) agar. Where appropriate, antibiotics were added at the following final 
concentrations: ampicillin 100µg/mL, spectinomycin 50µg/mL, chloramphenicol 35µg/mL, and 
kanamycin 50µg/mL. For long-term storage, transformed strains were frozen at -80°C in either 
7.5% dimethyl sulfoxide (DMSO) or 25% glycerol. Growth conditions for assaying of α-
farnesene production were modified as listed in the GC-MS analysis section below. Culture 
absorbance measurements were taken in microcentrifuge tubes with a Varian Cary 50 Bio UV-
Vis probe spectrophotometer. 
Synechococcus elongatus PCC 7942 
Synechococcus elongatus PCC 7942 (S. elongatus) (formerly Anacystis nidulans R2) was the 
cyanobacterial species used. S. elongatus was grown in blue-green medium #11 (BG-11) 
supplemented with 20mM HEPES/NaOH pH 8.1 at 34°C.112 For solid media, BG-11 was mixed 
with 1.5% (w/v) agar. Active liquid cultures were grown under 50μmol∙m-2s-1 of light and 60% 
humidity. Agar plates were also incubated under 50μmol∙m-2s-1 of light, except during the initial 
24 
 
stage of transformations. Light included in this measure was only photosynthetically active 
radiation (PAR) between 400 and 700nm. Light output was verified periodically with an LI-190 
quantum sensor and LI-250A light meter from LI-COR Biosciences. The source used for light 
production was Sylvania GRO-LUX F20T12 A/WS fluorescent lamps. Non-commercial 
incubators used are shown in Supplementary Figure  1. For long-term storage, transformed 
strains were frozen at -80°C in either 7.5% dimethyl sulfoxide (DMSO) or 25% glycerol. Culture 
absorbance measurements were taken in microcentrifuge tubes with a Varian Cary 50 Bio UV-
Vis probe spectrophotometer. 
DNA handling 
Oligonucleotides, synthetic double stranded fragments, laboratory DNA preparation 
All oligonucleotides for PCR were purchased from Integrated DNA Technologies with 
'standard desalting' as the only purification step. Lyophilised oligonucleotides were suspended in 
sterile double distilled water to a storage concentration of 100µM and stored at -20°C when not 
in use. Synthetic double stranded DNA fragments ("gBlocks Gene Fragments"), also purchased 
from Integrated DNA Technologies, were suspended from their lyophilised state and stored 
according to manufacturer instructions. 
Enzymatic procedures, including restriction digestion and phosphorylation, were carried out 
as specified by the manufacturer. Analytical and preparative gel electrophoresis were typically 
carried out with 0.8% (w/v) agarose gels and standard TAE buffer, under appropriate voltage, 
followed by ethidium bromide based visualisation.113 
Extraction of DNA from analytical/preparative agarose gels and clean up of enzymatic 
reactions were performed using spin column based kits according to manufacturer instructions 
(Thermo Scientific GeneJET and Qiagen). Plasmid DNA was prepared from E. coli cultures 
using spin column based 'miniprep' kits according to manufacturer instructions (Thermo 
Scientific GeneJET and Qiagen). 
Preparation of genomic DNA from S. elongatus was performed using a phenol-chloroform 
based extraction.46 Up to 50mL of culture was harvested by centrifugation and then suspended in 
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500µl 50mM Tris–HCl (pH 8.0) with 10mM EDTA, 100ul 0.6-mm-diameter glass beads, 25µL 
10% sodium dodecyl sulfate, and 500uL of phenol-chloroform (1:1, v/v). Cells were then 
disrupted by bead homogeniser with three 2min cycles at 3000rpm, with 2min rests between 
cycles. The aqueous phase was separated out by centrifugation three times, with a new, equal 
volume of chloroform being mixed in prior to centrifugation. Genomic DNA was then 
precipitated with 1/10 volume 3M sodium acetate (pH 5.2) and 2.5 volumes anhydrous ethanol (-
20°C) overnight. The precipitated DNA was then washed with 70% ethanol (-20°C), dried, and 
finally suspended in nuclease free water. 
PCR for DNA part generation  
High fidelity PCR for DNA part generation was carried out using Phusion High-Fidelity 
DNA Polymerase from Thermo Scientific or New England Biolabs. Fifty µl reactions were set 
up according to manufacturer instructions, including the addition of optional reaction 
components (1x HF buffer, 200µM dNTP mix, 0.5µM forward primer, 0.5µM reverse primer, 
1ng DNA template {200ng if genomic}, 3% DMSO, 1U polymerase, nuclease free water). 
Standard cycling conditions were employed (typical conditions: 98°C 30sec, 30 cycles:{98°C 
5sec, Primer annealing temperature +3°C 20sec, 72°C 15sec}, 72°C 5min). 
PCR for screening 
PCR based screening of cultures or colonies was done with ChoiceTaq DNA Polymerase 
(Denville Scientific). Primers used are listed in Supplementary Table 1. Fifty µl reactions were 
set up on ice according to manufacturer instructions (1x reaction buffer, 200µM dNTP mix, 
0.5µM forward primer, 0.5µM reverse primer, cell mass as template {quantity as appropriate}, 
2.5U polymerase, nuclease free water). When cells in liquid culture were required as the 
template, an aliquot of the culture was pelleted by centrifugation, washed with ddH20, and 
pelleted again. Standard cycling conditions were employed (94°C 2min, 30 cycles:{94°C 45sec, 





Plasmids and strains 
Plasmids and strains used in this study are listed in Table 4. S. elongatus transformants were 
generated by tri-parental mating as described in the following section. Natural transformation 
was also used, but found to be typically unreliable. E. coli transformants used to generate or 
maintain plasmids were generated using chemically competent cells.114 Plasmids made in this 
study were generated by directional restriction cloning and non-directional restriction cloning, 
unless otherwise indicated. DNA parts used in assemblies were generated from existing 
plasmids, PCR products (including multi-template SOEing115 products), and synthetic DNA 
fragments. Experimental plasmids were constructed with backbones derived from integrative 
shuttle vectors (pAM1573, pAM1579) from Susan Golden's laboratory at UC San Diego, 
modified versions of these vectors (pHN1_lacUV5) from Pamela Silver's laboratory at Harvard 
Medical School and, GeneArt's pSyn series shuttle vectors.48,116,117 Knockout vectors were 
generated with backbone components from pTrc99a.118 
Tri-parental mating for transformation of S. elongatus 
 Mating agar plates were prepared in 50mm diameter petri dishes with BG-11 agar 
supplemented with 5% (v/v) LB broth. Mating agar plates were then overlaid with sterile 
nitrocellulose disks. Alternatively, 250mm square plates can be used with multiple nitrocellulose 
disks per plate. One ml of S. elongatus culture (Abs750nm ≈ 1) was mixed with 100µl of an 
overnight culture of E. coli transformed with pRL443 and 100µls of an overnight culture of E. 
coli transformed with the S. elongatus shuttle vector of interest. Three plates were used for each 
transformation mixture: 10µl, 100µl, and the remainder of the mixture concentrated by 
centrifugation were spread on the nitrocellulose disks in the mating agar plates. The plates were 
then transferred to an incubator for 24-48 hours, cell side up, at a reduced (30μmol∙m-2s-1) light 
intensity. Reduced light intensity was achieved with cheesecloth or similar material. The 
nitrocellulose disk was then transferred with sterile tweezers to a new petri dish with BG-11 agar 
supplemented with the appropriate antibiotic. The selective plates were transferred to an 
incubator, cell side up, with full light intensity. False positives die under the selective conditions, 
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leaving behind putative transformant colonies. Colonies were then picking into 24-well plates 
containing selective BG-11 and grown under standard conditions. Antibiotic concentrations used 
for solid media: spectinomycin 20µg/ml, chloramphenicol 25µg/ml, and kanamycin 15µg/ml. 
Antibiotic concentrations for maintenance of liquid cultures were as follows: spectinomycin 
10µg/ml, chloramphenicol 10µg/ml, and kanamycin 10µg/ml. Concentrations were varied from 
those listed when multiple selection markers were present in a strain. 
Natural transformation of S. elongatus 
The following protocol is as described in the literature and updated from personal 
communications. 96,119,120 Synechococcus elongatus PCC 7942 is grown to an Abs750nm of 0.7. 
Approximately 15ml of culture is harvested by centrifugation for 10 minutes at 6000×g. The 
pellet is suspended in 1.5ml of sterile 10mM sodium chloride, transferred to a microcentrifuge 
tube, and harvested by centrifugation for 10 minutes at 6000×g. The pellet is then re-suspended 
in 300µl of BG-11. Fifty ng - 2µg of the DNA for transformation is added to the concentrated 
culture. Tubes are wrapped in aluminum foil and incubated shaking overnight at 30°C. Tubes are 
transferred to a shaking light incubator for four hours. Cells are spread (30µl and 270µl) onto 
pre-warmed BG-11 Nobel agar plates containing the appropriate antibiotic. Plates are incubated 





Table 4. Plasmids and strains in this study 
Plasmid Description (S. elongatus integration cassette contents) Reference 




pAM1573 Synechococcus-E. coli NS2 shuttle vector, AmpR and CmR 
(NS2a-CmR-NS2b) 
116 
pHN1_lacUV5 Synechococcus-E. coli NS3 shuttle vector, CmR 
(NS3a-PLacUV5-CmR-lacI-NS3b) 
48 
pTrc99a Contains lacIq cassette, AmpR 118 
pMTSa Contains top MVA pathway operon: PLACMTSa, CmR 
103 
pMBIS Contains bottom MVA pathway operon: PLACMBIS, TetR 
6 






pZW-(NS2:MCSe) pAM1573 derivative, enhanced multiple cloning site 
(NS2a-MCSe-rrnB-CmR-NS2b) 
This study 
pZW-(NS2:lacIq) pAM1573 shuttle vector derivative 
(NS2a-lacIq-rrnB-CmR-NS2b) 
This study 
pZW-(NS2:lacIq.MBIS) Synechococcus-E. coli NS2 shuttle vector, AmpR and CmR 
(NS2a- lacIq-PLACMBIS-rrnB-CmR-NS2b) 
This study 
pZW-psbA2aFS pUC57_simple derivative, PpsbA2-FS-TBBa_B1002 , AmpR 
Synthesized by GenScript  
104,122 & this study 
pZW-(NS3:lacI.FS) pHN1_lacUV5 derivative 
(NS3a- PLacUV5FS-CmR-lacI-NS3b) 
This study 
pZW-(2069-71:KmR) Knockout plasmid for Synechococcus, pTrc99a derivative, KmR 
(2069frag-KmR-2071frag) for targeted knockout of Synpcc7942_2069, 2070, 2071 genes 





Escherichia coli DH5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 ThermoFisher 
Synechococcus elongatus PCC 7942 
(Anacystis nidulans R2) 
Wild type 123 
ZW-(NS1:MevTSa-NS2:lacIq) S. elongatus strain, (NS1a-SpR-PLACMTSa-rrnB-NS1b ; NS2a-lacIq-rrnB-CmR-NS2b) This study 
ZW-(NS2:lacIq) S. elongatus strain, (NS2a-lacIq-rrnB-CmR-NS2b) This study 
ZW-(NS2:lacIq.MBIS) S. elongatus strain, (NS2a- lacIq-PLACMBIS-rrnB-CmR-NS2b) This study 
ZW-(NS1:MevTSa-NS2:lacIq.MBIS) S. elongatus strain, (NS1a-SpR-PLACMTSa-rrnB-NS1b ; NS2a- lacIq-PLACMBIS-rrnB-CmR-NS2b) This study 
 ZW-(2069-71:KmR) S. elongatus strain; Knockout of Synpcc7942_2069 (partial), 2070 (full), 2071 (partial); KmR 
Δ(2144977-2147246):KmR 
99 & this study 
Abbreviations: SpR - spectinomycin resistance cassette, AmpR - ampicillin resistance cassette, CmR - chloramphenicol resistance cassette, TetR - tetracycline resistance cassette, 
KmR - kanamycin resistance cassette, NS# - S. elongatus neutral integration site (genomic homology region), lacI/lacIq - lac repressor 
Note 1: Current pSyn plasmids (version 2.0, 2013 release) offered by GeneArt differ from their original release (version 1.0, 2012 release.) 







GC-MS analysis  
Mevalonate was analysed by conversion to mevalonolactone. Five hundred and sixty µl of 
culture was added to 140µl of 500mM hydrochloric acid and vortexed. Seven hundred µl of ethyl 
acetate was added to the mixture, followed by vortexing immediately for 5 minutes. The ethyl 
acetate phase was then transferred to an autosampler vial for analysis. Gas chromatography 
analysis was carried out with an Agilent 6890N gas chromatograph, 7683B injector, 5975C mass 
spectrometer, and Agilent DB-5MS (25m×0.2mm, 0.33µm film thickness) column. Oven 
program was as follows: Initial 60°C for 2 minutes, increased to 125°C at 60°C/minute, 
increased to 140°C at 5°C/minute, increased to 300°C at 80°C/minute, and hold at 300°C for 3 
minutes. Samples were injected in 2µl volumes in pulsed-splitless mode. The injection inlet was 
maintained at 200°C. Hydrogen carrier gas was used, maintaining a purge flow of 60ml/minute 
and flow of 20ml/minute. Samples exiting the oven passed through a 240°C MSD transfer line, 
and onto the MS source at 230°C, MS quad at 150°C. Data was recorded at the detector 
following a 3.7 minute solvent delay, with m/z 43, 58, and 71 monitored as representative ion 
masses. Standard curves for DL-mevalonolactone were prepared as shown in Figure 3A-B. 
Mevalonate feeding was carried out with DL-mevalonate converted from 1 volume 2M DL-
mevalonolactone with 1.02 volumes 2M KOH.6  
Strains containing genes for farnesene synthesis were grown as 5ml cultures in 2YT medium 
with a 1ml decane overlay at 34°C. Volumes for analysis were taken directly from the decane 
overlay.  Gas chromatography analysis was carried out with an Agilent 6890N gas 
chromatograph, 7683B injector, 5975C mass spectrometer, and Agilent DB-5MS column. Oven 
temperatures were as follows: 60°C for 2 minutes, increased to 160°C at 50°C/minute, increased 
to 170°C at 3°C/minute, increased to 300°C at 50°C/minute, 300°C for 3 minutes. Two µl of 
samples were injected with an inlet temperature of 250°C, purge flow 60ml/minute, flow 
20ml/minute, pulsed-splitless mode injection, hydrogen carrier gas, 240°C MSD transfer line, 
230°C MS source, 150°C MS quad, and 3.7 minute detector solvent delay. Representative ion 
masses monitored were 105, 161, 204 m/z. A standard curve for farnesene was prepared using an 




One ml aliquots of culture were taken and centrifuged to pellet in amber microcentrifuge 
tubes. The supernatant was discarded and 1ml of 100% methanol was added. Tubes were then 
vortexed for 10 minutes in the dark for pigment extraction. Cultures were again pelleted to 
remove cell debris. Chlorophyll determination was carried out by absorbance recordings at 
663nm in a 1cm cuvette.43,124  
HPLC analysis of carotenoids 
Sample extraction was carried out in the same manner as for chlorophyll quantification. 
Methanol extracts were transferred to amber autosampler vials for analysis. Carotenoids were 
separated by HPLC on a Agilent Zorbax Eclipse XDB-C18 column (3.5µm, 150×4.6mm) using a 
15 minute gradient of ethyl acetate (0-100%) in an acetonitrile-water-triethylamine solution 
(9:1:0.01, vol:vol:vol) at 1.5ml/minute.43 β-carotene was identified by its typical retention time 






Figure 3. Standard curves used for quantitative analysis of metabolites 
(A) DL-Mevalonolactone standard curve for GC-MS analysis using selected ion monitoring data. (B) DL-
Mevalonolactone standard curve for GC-MS analysis using total ion count data. (C) β-carotene standard curve for 
HPLC analysis. (D) Farnesene (isomeric mixture) standard curve for GC-MS analysis using total ion count data. (E) 
GC chromatogram of farnesene (isomeric mixture) used to generate the standard curve shown in D. Insert shows 
magnified section of chromatogram, with arrows indicating major farnesene isomer peaks. 
(A) Eq. 1: Mevalonolactone 1 standard curve fit  
𝑦 = (0.0002𝑥 + 4.47416) × 0.118 × (6 0.7⁄ ) ; 𝑅2 = 0.9996 
(B) Eq. 2: Mevalonolactone 2 standard curve fit 
𝑦 = (0.0002𝑥 + 17.726) × 0.118 ; 𝑅2 = 0.9859  
(C) Eq. 3: β-carotene standard curve fit 
𝑦 = (0.0002𝑥 + 1.491) ; 𝑅2 = 0.9884  
(D) Eq. 4: Farnesene isomers standard curve fit 




Transformations of S. elongatus 
Both natural transformations and tri-parental mating were employed as methods to obtain 
transformed S. elongatus strains. Use of natural transformation has been reported extensively in 
the literature but was not a reliable method of transforming S. elongatus in my hands. Natural 
transformation positive controls generally resulted in dense lawns. With this method, colony 
forming units were not reliably countable; even with serial dilutions plates tended to have diffuse 
growth rather than punctiform/circular colonies. Experimental conditions varied for this method 
included antibiotic concentration, starting culture density, incubation time, recovery time, and 
plasmid concentration. Based on these results, tri-parental mating was tested for as an alternative 
method for transforming DNA into S. elongates. No experimental strains discussed in the 
following sections were generated by the natural transformation method. 
Tri-parental mating for transformation of S. elongatus is uncommon in the literature due to 
increased complexity and cost. The nitrocellulose disk used with the mating method provided 
improved anchorage for colonies and recorded conjugation efficiencies were up to 8×10-2 
colonies/CFU. Positive confirmation of colonies by PCR after growth in liquid culture, as shown 
in the proceeding sections, was typically less than 10%. 
Microbial contamination of strains was common both during and after transformation 
procedures, and contaminating species varied. Contaminating species were typically visible only 
after enrichment overnight on 2YT agar or as micro-punctiform colonies. As other species have 
the potential to alter the metabolic profile of a sample, contaminated samples were not included 
in analyses. 
Validation of PCR screen for S. elongatus integration events 
Following tri-parental mating and selection, successful integration of heterologous 
mevalonate pathway genes into S. elongatus was initially verified by PCR screening carried out 




Figure 4. Validation of PCR based screen for S. elongatus chromosomal integration events 
Two reactions are carried out at each temperature in the gradient. The negative control 'WT' reaction uses wild type 
S. elongatus cell mass used as the PCR template. The 'P' reaction uses a gene specific plasmid. ERG12, ERG8, 
MVD1, idi, ispA, lacIq use pZW-(NS2:lacIq.MBIS). atoB and ERG13 use pMTSa. Ladder is Generuler 1kb+ by 
ThermoFisher. Bottom bands in lanes without ladder are primer dimers.  
 
specificities for the PCR screening used on putative transformants. Nine target sequences were 
validated for their viability in screening. Template DNA used for validation was 1) a plasmid 
containing the mevalonate pathway and related genes (positive control) and, 2) wild type S. 
elongatus pelleted cells (negative control). PCR conditions, except annealing temperature, were 
consistent for all reactions. At the highest annealing temperature used (60°C), no significant non-
specific bands appeared in the agarose gel electrophoresis analysis of the reactions, with the 
exception of primer dimers (Figure 4). Non-specific priming on the S. elongatus genome was 
seen in three out of eight of the primer pairs and, was greatest at lower PCR annealing 
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temperatures. PCR of the HMGR-Sa gene was unsuccessful on multiple occasions. Each instance 
of non-specific priming occurred where the target DNA sequence was of bacterial origin, as 
opposed to from Saccharomyces cerevisiae (Figure 2). From these screen validation results it can 
be concluded that when using a 60°C annealing protocol this PCR screening method is highly 
specific for the target DNA and false positives from genomic mispriming are unlikely. 
Mevalonate biosynthesis by S. elongatus cells harboring a recombinant upper 
mevalonate pathway 
The three-gene upper-portion of the mevalonate pathway (MevT) was stably integrated into a 
S. elongatus strain carrying the lac repressor by tri-parental mating. These three genes, atoB, 
ERG13, and HMGR-Sa, were contained in a single operon (MevT-Sa.) This operon was under 
the control of a standard inducible bacterial lac promoter (PLac) (Table 4).  
S. elongatus colonies from the selective post-conjugation plates to be tested for positive 
integration of the 3-gene pathway were picked and used to inoculate BG-11 cultures. Once 
cultures were a pale to medium green colour, 200µl from each culture was harvested by 
centrifugation. Cell lysates were used as template for verification by PCR that the MevT operon 
was present in the cells. Screening was carried out with atoB_fwd and ERG13_rev primers, 
resulting in a longer DNA fragment size than seen in the method validation shown in Figure 4. 
As done previously, the positive control used a plasmid DNA template and the negative used 
wild type cell mass. Only one out of seventeen cultures screened for MevTSa integration was 
shown to contain the heterologous DNA (Figure 5). The PCR product generated from this strain 





Figure 5. Verification of upper MVA pathway integration by PCR. 
Ladder is Generuler 1kb+ by ThermoFisher. 'S' denotes experimental S. elongatus strains. Sample S12 represents the 
only successful integrant in this screen where the upper band matches expected atoB-ERG13 fragment size. 
Negative control with wild type S. elongatus. Positive control with pMTSa plasmid. Bottom bands in lanes without 
ladder are primer dimers.  
 
To test for functionality of the chromosomally-integrated upper mevalonate pathway in the 
engineered S. elongatus, cells were tested for the production of mevalonate. Four biological 
replicate cultures of S. elongatus containing the MevT-Sa operon were grown under maintenance 
conditions until log phase was reached after approximately four days. The four cultures were 
then diluted to 0.1 Abs750nm (time 0 - t0) and split into two sets of flasks. IPTG was added to one 
of the sets at t0 to induce MevT operon expression. Cultures were tested for contamination by 
spot plating 10µl of each culture onto LB agar plates at each analysis time point. No 
contamination was recorded in any of the samples during this time course. At the same time a 
sample was taken for spot testing, additional samples were taken to monitor cell density and for 
mevalonate analysis.  
Similar growth rates were recorded for both induced and uninduced cultures, although the 
statistical confidence interval (and standard deviation) for the absorbance measurements were 




Figure 6. Mevalonate biosynthesis in a S. elongatus strain containing an upper MVA pathway 
Mevalonate production by the ZW-(NS1:MevTSa-NS2:lacIq) S. elongatus strain. (A-C) show cultures without (◊) 
and with (□) 500µM IPTG inducer added. (A) Growth curves of the uninduced/induced strains. (B-C) GC-MS 
analysis of mevalonate production for the uninduced/induced strains. (D-F) show the same cultures re-plotted into 
non-expressing/low-mevalonate (∆) and expressing/high-mevalonate (○) groups. (D) Growth curves of the 
regrouped strains. (E-F) GC-MS analysis of mevalonate production for the regrouped sets of strains. Mevalonate 
was measured indirectly following acidification of samples to form mevalonolactone. Error bars indicate the mean ± 




Solvent extracted samples were analysed for mevalonate by GC-MS. Measured ion counts 
were converted to molar concentrations based on a standard curve and then normalized to cell 
density. Figure 6B shows the individual replicates for uninduced and induced cultures at each 
time point. Averaging these replicates (Figure 6C) results in the 95% confidence interval being 
approximately as large as the measurements themselves, suggesting no correlation between strain 
induction and mevalonate production. 
Figure 6E shows the same individual data points reorganized into low and high mevalonate 
concentration samples. All previous data points were retained. These re-clustered data points are 
shown averaged together in Figure 6F. Both low and high mevalonate categories are noted to 
remain at approximately the same concentration, at a 95% confidence interval, between the 
measured time period of 48-121 hours. When re-clustered in this way, growth rates (Figure 6D) 
remain similar in appearance, with limited change in the mean growth rates and associated 
confidence intervals.  
Analysis of mevalonate content in these culture extracts demonstrates that 1) mevalonate 
production under the control of PLac is independent of IPTG induction in this system and, 2) that 
two distinct populations of mevalonate producing cells were present. One population produced 
just under 20µM/Abs750nm, while the other was approximately four times higher at 
80µM/Abs750nm (Figure 6E-F). 
Mevalonate uptake and utilization by S. elongatus cells harbouring a lower 
mevalonate pathway 
Conjugation based integration of the five-gene lower half of the mevalonate pathway was 
also screened for by PCR. Both pZW-(NS2:lacIq.MBIS) containing the lac repressor and the 
lower MVA pathway and, pZW-(NS2:lacIq) containing only the lac repressor were transformed. 
The PCR screening was performed directly on pelleted cell mass from liquid cultures of putative 
transformants, as described in the previous section. 
The lac repressor PCR product seen from both recombinant strains clearly shows the 
presence of the gene in these strains (Figure 7). The presence of the ERG12 PCR product for the 




Figure 7. Verification of lower MVA pathway integration by PCR. 
Ladder is Generuler 1kb+ by ThermoFisher. 'S' denotes experimental S. elongatus strains. '1/10' denotes dilution of 
cell culture template by factor of 10. Upper bands in S1/10 columns match expected product sizes. (lacIq used for lac 
repressor screen; ERG12 used for lower MVA screen.) Negative control with wild type S. elongatus. Positive 
control with corresponding pZW-(NS2:lacIq) and pZW-(NS2:lacIq.MBIS) plasmids. Genomic DNA can be seen 
retained at the top of the agarose gel in S and S1/10 lanes. ' * ' denotes lane with failed positive control for lower 
MVA pathway. 
 
strain. Although previously validated (Figure 4), the positive control for the lower MVA 
pathway PCR reaction failed (Figure 7). 
Functional screening of the MBIS-harbouring recombinant strains was carried out by 
measuring mevalonate utilization. Both NS2:lacIq and NS2:lacIq.MBIS strains were grown in 
quadruplicate in the presence of IPTG and displayed growth rates with no significant differences 
at the 95% confidence interval (Figure 8A). These similar growth rates suggest no apparent 
metabolic burden in the strain caused by the lower MVA genes. Cultures were tested for 
contamination by spot plating 10µl of each culture onto LB agar plates at each analysis time 
point. No contamination was recorded in any of the samples during this time course. No change 
in mevalonate concentration, which would point to a functional lower mevalonate pathway, is 
seen in either the experimental NS2:lacIq.MBIS strain or NS2:lacIq control strain (Figure 8B). 
This lack of utilization of mevalonate by the lower MVA strain suggests either pathway 





Figure 8. Mevalonate feeding in S. elongatus harbouring a lower MVA pathway 
Metabolism of fed mevalonate by the ZW-(NS2:lacIq.MBIS) S. elongatus strain (□) and the control ZW-(NS2:lacIq) 
strain (◊). (A) Growth curves of the strains with supplemented mevalonate. (B) GC-MS analysis of the total 
mevalonate present in the cultures over the recorded growth period. Mevalonate was measured indirectly following 




Changes to host metabolism while harbouring a complete heterologous 
mevalonate pathway 
To test if limited intracellular substrate availability was responsible for the lack of 
mevalonate utilization, the upper MevT-Sa operon-(NS1:MevTSa plasmid) was integrated into 
NS2:lacIq.MBIS by tri-parental mating. Successful integration of both the upper and lower 
mevalonate pathway operons into a single strain was once again screened by PCR following 
selection and growth of putative transformants on the appropriate antibiotics (Figure 9). Two 
correct transformants were recovered out of the thirty cultures screened. One of these 
transformants shown in Figure 9, strain S7, was then chosen for functional screening. The 
presence of PCR products for both the lower ('B' lane) and upper ('T' lane) clearly demonstrates 





Figure 9. Verification of complete MVA pathway integration by PCR. 
Ladder is Generuler 1kb+ by ThermoFisher. 'S' denotes experimental S. elongatus strain. 'B' denotes the lower 
(bottom) MVA pathway and 'T' the upper (top) MVA pathway. Bands in S columns match expected product sizes. 
(ERG12 used for bottom MVA screen; atoB used for the top MVA screen.) Negative control with wild type S. 
elongatus. Positive control pZW-(NS2:lacIq.MBIS) plasmid for bottom MVA pathway ('B') and pMTSa for top 
MVA pathway ('T'). Bottom bands in lanes without ladder are primer dimers.. 
 
Chlorophyll content in the MVA containing strain  
As chlorophyll a is an isoprenoid derivative and is often used to characterise algal growth, 
chlorophyll a content over time (Figure 10C) was characterised by bulk absorbance 
measurements at 663nm. The S. elongatus strain containing the complete heterologous 
mevalonate pathway was grown in parallel with wild type S. elongatus and chlorophyll was 
extracted. At a 95% confidence interval the growth rates of the recombinant and wild type strains 
showed no significant differences in most of the recorded time points (Figure 10A). When the 
confidence interval is reduced to 90%, a consistent decrease in growth rate is apparent for the 
double integrant stain over the first 54 hours of growth, indicating that the recombinant strain is 
subject to an increased metabolic burden compared to the wild type (Figure 10B). At 18 hours of 
growth, the total chlorophyll a was 26% higher for the wild type strain versus the experimental 
strain. At a 95% confidence interval there was no significant difference between total chlorophyll 
a content following the first time point, with the exception of hour 54. At hour 54 the 
experimental strain had an 8.8% higher total chlorophyll a concentration. 
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When chlorophyll a content is normalised to culture density, a different trend can be seen 
(Figure 10D). At 18 hours there is no significant difference between the wild type and the 
engineered strain. For the remainder of the time course, the normalised chlorophyll a 
concentration is 25 to 37% higher in the engineered strain. While the total chlorophyll a content 
trends upwards for both strains over the time course, the concentration is shown to trend 
downwards when normalised to culture density.  
To examine the differing rates of chlorophyll and biomass accumulation, the same data set is 
shown normalised to the maximum value for each condition in Figure 10E-F. In wild type cells, 
the rate of chlorophyll accumulation is higher earlier in growth. By 18 hours, the wild type strain 
has accumulated 80% of its maximum chlorophyll content compared with only 60% of the 
maximum for the modified strain. For both strains the culture densities have reached 
approximately 50% of their maxima at this time point. Differences in maximum quantities for 
both chlorophyll and culture density are not statistically significant between the wild type and 
engineered strains. From these differences in chlorophyll a accumulation, we can speculate that 
inclusion of a complete MVA pathway has a direct effect on central metabolic processes in S. 








Figure 10. Chlorophyll a biosynthesis in a MVA pathway containing S. elongatus strain 
Analysis of chlorophyll a production in a S. elongatus strain containing a complete heterologous mevalonate 
pathway. (A-D) (◊ and blue bars) show the wild type S. elongatus and, (□ and red bars) show the ZW-
(NS1:MevTSa-NS2:lacIq.MBIS) strain. Growth curves of the strains are shown with error bars indicating the mean 
± 95% confidence interval (A) and ± 90% confidence interval (B). (C) Total chlorophyll a content is compared 
between the strains. (D) Chlorophyll a content normalised to culture growth is compared. (E) Culture growth (○) and 
chlorophyll accumulation (●) normalised to their recorded maximums for the control strain. (F) Culture growth (∆) 
and chlorophyll accumulation (▲) normalised to their recorded maximums for the heterologous mevalonate 
pathway strain. Culture density (750nm) and chlorophyll a content (663nm) were both measured by 
spectrophotometer. Error bars indicate the mean ± 95% confidence interval of the biological replicates, except as 
indicated for (B).  
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β-Carotene content  
The same cultures used for chlorophyll analysis were also analyzed by HPLC for changes to 
β-carotene content as a general indicator of cellular isoprenoid production. The strain expressing 
the heterologous mevalonate pathway showed no statistically significant trend in total β-carotene 
levels compared to the wild type strain (Figure 11A). However, differences were apparent when 
β-carotene content was normalised to culture density (Figure 11B). At a 95% confidence 
interval, normalised β-carotene content is seen to be higher in the engineered strain up until hour 
42. At a 90% confidence interval, all time points except at hour 54 show significantly higher 
normalised β-carotene content. From this we can conclude that the recombinant strain maintains  
 
 
Figure 11. β-carotene biosynthesis in a MVA pathway containing S. elongatus strain 
Analysis of β-carotene production in a S. elongatus strain containing a complete heterologous mevalonate pathway. 
(◊) show wild type S. elongatus and (□) show the ZW-(NS1:MevTSa-NS2:lacIq.MBIS) strain. β-carotene was 
measured by HPLC. (A) Total β-carotene content in the cultures. (B) β-carotene content normalised to culture 
growth. (C) The ratio of β-carotene to chlorophyll a shown normalised to the highest recorded ratio. Error bars 
indicate the mean ± 95% confidence interval of 3 (◊) or (□) 5 biological replicates.  
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higher concentrations of the isoprenoid β-carotene even as concentrations drop during the 
stationary growth phase. 
In the wild type cells, the ratio of β-carotene to chlorophyll shows limited variation over the 
time course (Figure 11C). This contrasts with the engineered strain where, a downward trend in 
the β-carotene:chlorophyll ratio is apparent, similar to that seen in the β-carotene:Abs750nm 
values. The ratio of β-carotene to chlorophyll shows a similar trend to that of β-carotene to 
culture density. From these ratios we can conclude that β-carotene is a potential sink for 
additional flux of isoprenoid precursors generated by the MVA pathway. This relationship is 
considered further in the Discussion. 
Biosynthesis of α-farnesene 
For a direct measurement of increased isoprenoid flux in the engineered S. elongatus, an α-
farnesene synthase, previously codon optimised for E. coli by Wang et al., was synthesised and 
expressed under the control of the native S. elongatus psbA2 diurnal promoter. To validate the 
functionality of the encoded protein, the farnesene synthase was cloned into the pHN1_lacUV5 
shuttle vector under the control of a lac promoter to form pZW-NS3:lacI.FS and transformed into 
E. coli. The synthase is known to produce a single isomer of farnesene, however, I was unable to 
obtain an analytical standard containing only α-farnesene and instead used an isomeric mix. As 
the multiple isomers were resolved as separate peaks during GC-MS analysis, all peaks were 
integrated and summed together to construct the standard curve (Figure 12A).  
E. coli cultures harbouring the synthase-expressing plasmid were grown under selection at 
37°C and diluted to a starting Abs600nm of 0.05 (Figure 12B). Cultures were then switched to 
34°C to better approximate S. elongatus growth conditions and overlayed with decane to trap 
produced farnesene. After approximately 9 hours, cultures reached an Abs600nm of 0.5 and one set 
of the cultures had IPTG inducer added. Decane samples were taken at the time of induction as 
well as at 12 and 24 hours post induction. At 12 and 24 hours post-induction, culture density in 
the induced samples was noted to be higher. Farnesene was already detectable at the time of 
induction and total extracted farnesene increased only slightly over the following 24 hours. 
(Figure 12C-D). From these data from E. coli data, it was concluded that the synthase is 
functional in its expression system.  
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Integration of the synthase-expressing pZW-NS3:lacI.FS into S. elongatus was attempted, 
but was unsuccessful. PCR based screening, as described previously, was carried out on putative 
transformants (Figure 13).  
 
 
Figure 12. Functional testing of the α-farnesene synthase in a S. elongatus shuttle vector 
Functionality of farnesene synthase in a S. elongatus shuttle vector determined by GC-MS. The pZW-NS3:lacI.FS 
plasmid was expressed in E. coli in a two-phase culture of 2YT medium and decane. (A) The upward y-axis shows 
the GC-MS chromatogram used to generate a standard curve (farnesene, isomeric mixture - 181µM). The downward 
y-axis shows an experimental chromatogram (α-farnesene - 11.7µM). (B-D) show cultures without (◊) and with (□) 
500µM IPTG inducer added. (B) Growth curves of the cultures are shown. (C) Total α-farnesene content for the 
uninduced and induced cultures is shown.. (D) α-Farnesene content normalised to culture growth is compared for 





Figure 13. Screening for farnesene synthase integration by PCR. 
Ladder is Generuler 1kb+ by ThermoFisher. 'S' denotes experimental S. elongatus strain. Positive control uses a 
490bp segment (lower, higher intensity band) of the farnesene synthase from pZW-NS3:lacI.FS. Negative control 
with wild type S. elongatus. Bottom bands in lanes without ladder are primer dimers. 
 
Genetic knockout induced biofilm formation in S. elongatus 
Optimal light harvesting in evanescent-field based photobioreactors requires a constant 
monolayer of cyanobacteria along the waveguide surface. Use of a biofilm phenotype was 
hypothesised to allow consistent light and nutrient availability to such a cell monolayer in this 
type of photobioreactor. Currently, the only reported biofilm phenotype in S. elongatus was 
reported by Schatz et al. in 2013. Their strain displayed a distinct biofilm phenotype, as well as a 
loss of competence. The authors showed that a knockout of S. elongatus gene 2069 or gene 2071 
was necessary and sufficient under normal conditions to generate the phenotype in wild type 
cells (Figure 14A). Because of the competency loss, I constructed a knockout vector - analogous 
to that used by Schatz et al. - which could be used as a final transformation with any 
experimental strain (Figure 14B).   
Transformation by bacterial conjugation was attempted with an appropriate, broad range of 
kanamycin concentrations (5, 10, 15, 20, 25µg/ml) on solid media. Individual colonies were then 
transferred to liquid media in 24-well plates under continued selection or re-streaked and then 
transferred to liquid media. Over multiple rounds of conjugation, in excess of 200 colonies were 
screened for phenotypic changes. I was unable to reproduce the desired biofilm phenotype under 





Figure 14. S. elongatus biofilm-related genome features 
S. elongatus biofilm phenotype-associated locus. (A) Shows the genomic region containing biofilm linked genes. 
Each block is a native gene listed with its identification number. Genome nucleotide positions are listed above the 
blocks. (B) Shows the functional components of an insertional knockout plasmid. The recombination event is 
selected for by the kanamycin resistance cassette shown between the genomic sequence fragments. Not shown is the 





Photosynthetic isoprenoid production for commodity chemicals 
Biosynthetic farnesene production has been demonstrated in a variety of industrial 
microorganisms. Production in S. cerevisiae is now commercially viable, with it being sold under 
the trade name Biofene by Amyris.125 While I was able to demonstrate only preliminary 
functionality an α-farnesene production vector for use in S. elongatus here, similar work done in 
other cyanobacteria species and with different target molecules suggests the strategy proposed 
here is feasible (Table 1). A 2.5-fold increase in heterologous isoprenoid production in the 
related Synechocystis species when a complete MVA pathway was expressed suggests 
isoprenoid production can benefit in this type of host by the inclusion of the MVA pathway.67 
Because the endogenous MEP isoprenoid pathway in S. elongatus is directly linked to 
multiple components of the photosynthetic process (i.e. chlorophyll and carotenoids) (Figure 1), 
balancing metabolic flux in a strain with engineered MEP over-expression may be more 
challenging. Engineering efforts for increasing production of heterologous isoprenoids by 
increasing flux through the endogenous MEP pathway have focused on pushing more carbon 
into the pathway by the addition of a DOXP synthase (Figure 1) and pulling more carbon out of 
the pathway into the required isoprenoid pyrophosphate building block, both of which are rate 
limiting steps in the MEP pathway (Table 1).126 When this type of MEP pathway engineering 
was done for heterologous limonene production in Synechocystis, production was only seen to 
increase 1.36-fold.127 In the unrelated Anabena sp. PCC 7120, production increased 2.3-fold in 
comparable environmental conditions, although at substantially lower titres.68 
When this strategy was followed in E. coli for amorphadiene (a sesquiterpene) production, 
the production increase was comparable, at a 3.6-fold improvement.6 When heterologous 
expression of a MVA pathway was carried out rather than targeted improvement to the 
endogenously regulated MEP pathway, amorphadiene yield increased a further 10-fold.6 
A large proportion of published work in this area with cyanobacteria has focused on 
generating a basic strain that produces a specified isoprenoid and improving production by 
means other than metabolic engineering. Demonstrating increased production titres under higher 
light conditions or specialised photobioreactor designs are common strategies for this.66–
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68,78,128,129 Given the relatively low titre improvements demonstrated under standard laboratory 
conditions in cyanobacteria, significant gains can be expected in the future. A variety of early 
efforts in improving MVA-based isoprenoid production in E. coli readily generated 
improvements, including order-of-magnitude production increases.6,100,101,103 As has been 
demonstrated, only over-expressing of enzymes is not always the best choice in pathway 
engineering if the efficiency of that reaction is not optimised for the context it is occurring in.100 
At the most basic level, the production host and even growth stage of the host can impact 
functioning of an enzyme. Some effective improvement strategies have included balancing off-
target effects by cell-wide functional genomics analysis, screening enzyme variants for optimal 
context-dependent kinetics and cofactor use, and reduction of metabolic burden by physically 
associating pathways to synthetic protein scaffolds for improved efficiency.101–103 
Examination of metabolic intermediates in isoprenoid biosynthesis 
I am currently unaware of any studies examining heterologous mevalonate production in 
cyanobacteria, particularly those closely related to S. elongatus. Determining the concentrations 
of intermediate metabolites can provide insight into flux bottlenecks in a pathway.  
In the upper MVA HMGR variants tested using E. coli by Ma et al., including the S. aureus 
variant used in this study, the measured mevalonate concentration roughly correlated to 
concentration of the final heterologous isoprenoid molecule.103 My measurements in S. elongatus 
showed a maximum mevalonate concentration of 70µM. While not atypical of results shown in 
photosynthetic systems, the reported mevalonate concentration using the same system in E. coli 
was more than 30-fold higher.103 
When isoprene production was carried out in Synechocystis by Bentley et al., the addition of a 
different complete MVA pathway only increased isoprene production from 1.9 to 4.7µM.67 As 
one isoprene unit is generated per molecule of mevalonate, this suggests the MVA pathway used 
by the authors operates at a lower efficiency than the MVA pathway tested here. (Isoprene is 
rapidly lost into the headspace and is unlikely to be implicated in reduced pathway efficiency.) 
The authors chose to construct a MVA pathway with parts of bacterial origin to increase the 
chances of functional expression in their host and, the chosen isoprene synthase plus MVA 
pathway had been previously used in E. coli. In E. coli, introduction of the MVA pathway 
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resulted in an order of magnitude improvement.130 In Synechocystis, the authors reassembled the 
pathway with different transcription/translation control sequences. The reassembly of their 
pathway may have resulted in a negative effect on its efficiency in the new host and 
correspondingly poor increase in isoprene production. Additionally, although the MVA genes 
were shown to be functional in E. coli, and protein accumulation was shown in Synechocystis, it 
is possible the new host exerted an unobserved regulatory effect on one of the translated proteins. 
When a complete MVA pathway was expressed in the S. elongatus host, total measured β-
carotene content (the major isoprenoid sink) was maximally 3µM (24µM mevalonate equivalent) 
higher than the wild type (Figure 11). If β-carotene was the only available carbon sink, it would 
suggest a pathway bottleneck. Since limited regulatory feedback from the cell on the 
heterologous MVA pathway can be expected, it is likely any negative regulation is occurring in 
the endogenous carotenoid pathway or that the carbon is being distributed more broadly to other 
endogenous isoprenoid derivatives. These would include pigments normally found in lower 
relative abundance and to phytol for chlorophyll a biosynthesis. 
Because additional fixed carbon, ATP, and reducing equivalents are consumed by the MVA 
pathway (Figure 1), more must be generated to ensure regular functioning of the cell. Under light 
saturating conditions, significant growth defects when pulling fixed carbon into an engineered 
sink molecule are uncommon. When a carbon sink is present, increased photosystem II activity 
has been recorded (as measured by oxygen evolution).68 While I did not measure rate changes in 
oxygen evolution, it would not be unreasonable to assume that the expressing the MVA pathway 
alone could also result in increased oxygen evolution. Expression of only the MVA pathway still 
diverts fixed carbon and energy away from endogenously regulated processes. This would 
necessitate increased photosynthetic activity to maintain a consistent growth rate.  
The maximal production of 70µM of mevalonate in S. elongatus was done with the PLAC 
promoter. While functional, PLAC is known to be a weak foreign promoter in cyanobacterial 
systems. The demonstrated plasticity in cyanobacterial systems to fulfill the carbon and energy 
needs saturating light conditions suggests that use of a stronger foreign promoter would cause a 
corresponding increase in flux through the MVA pathway. 
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When the full MVA pathway was expressed here in S. elongatus, a small growth rate defect 
was detectable. As carbon, ATP, and NADPH do not seem to be limiting factors, the two most 
likely possibilities appear to be limited availability of transcription/translation machinery, or 
more likely, increased burden from continued selective pressure with two antibiotics. 
Addition of the inducer IPTG had no apparent effect on mevalonate product levels. This 
suggests that although PLAC can drive transcription in S. elongatus, the lac repressor is ineffective 
in this context with PLAC. 
Curiously, in two out of the four strain lineages a deficiency in mevalonate production was 
clearly present. In the analysis I reclassified the cultures from uninduced/induced to low/high 
expressing. If we assume a proportional increase in mevalonate concentrations with pathway 
copy number, the data suggests complete chromosome segregation occurred in only two of the 
lineages. Mean maximum mevalonate concentrations are approximately 4-fold greater in the 
high expressing cultures. Given that the median (and modal) number of chromosomes is 4 copies 
per cell (with approximately 1/3 of cells having 4 copies) it is likely the low expressing lineages 
were only carrying one correct chromosome per cell on average.97 Gene dosage has previously 
been described as a design concern for systems in another cyanobacterial polyploid, 
Synechocystis sp. PCC 6803.109 
Relationship between chlorophyll, carotenoids, and isoprenoid flux  
When I assessed chlorophyll a production in S. elongatus after the addition of a MVA 
pathway I saw the engineered cells maintained an equivalent per cell quantity of chlorophyll 
compared to the wild type during log phase (18 hours; Figure 10). The lower total chlorophyll 
quantity in the MVA strain at this time point can be attributed to the slightly lower rate of growth 
of the strain.  
As the strains exit their log phase growth, per cell chlorophyll content drops by more than 
25% in the wild type strain while the MVA containing strain maintains its per cell chlorophyll 
content (Figure 10). For the remainder of the measured time points chlorophyll content gradually 
decreases in both strains, but the per cell values for the MVA containing strain remain at least 
20% higher than the wild type. It could be presumed that the retention of higher per cell 
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chlorophyll concentrations is due to the increased requirements for fixed carbon, ATP, and 
reducing equivalents by an active MVA pathway. The decreased chlorophyll concentration in the 
wild type can likely be considered a quantity sufficient for housekeeping once biomass 
generation begins to slow down.  
The β-carotene concentrations display a similar trend of staying higher in the MVA strain 
after entering late log phase (Figure 11). However, unlike the equal amounts seen with 
chlorophyll, more β-carotene is seen on a per cell basis at the first time point in the MVA stain. 
This suggests that the regulation of carotenoid biosynthesis is not as strict as with chlorophyll a. 
Consideration should also be given to the possibility that reduction of per cell β-carotene 
concentrations over time is due to self-shading within the culture and a reduced need for photo-
protection.  
No clear trend is apparent in the ratio of β-carotene to chlorophyll over time in either strain. 
This ratio stays relatively consistent for the wild type strain at all time points. This suggests that 
β-carotene content is directly linked to the requirements of the photosystems for it in the wild 
type strain under the light intensity used here. The greater β-carotene content relative to 
chlorophyll in the MVA strain reinforces the idea that β-carotene can be assumed to be a sink for 
the additional flux of isoprenoids precursors generated by the MVA pathway and changes to 
chlorophyll levels are related to the level of photosystem activity required to meet the metabolic 
demands of the cell. 
S. elongatus permeability to metabolites 
In the lower MVA pathway strain, I was unable to generate a co-transformant containing a 
heterologous farnesene synthase that could act as a carbon sink. Because of this, to assay the 
functionality of the lower pathway alone, I chose to screen for consumption of mevalonate rather 
than product formation. 
When fed with mevalonate, no reduction in mevalonate concentration was detectable in the 
cultures (Figure 8). This effect has two likely causes. The first potential cause is pathway 
inactivity, either by extremely low processivity by the yeast mevalonate kinase (ERG12) in S. 
elongatus or knockdown by the heterologous host. 
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While ERG12 catalyzes an ATP consuming reaction it is unlikely that ATP availability 
would limit this reaction. No significant growth defect was seen during strain growth. 
Additionally, increased metabolic burden on cyanobacteria appears to be linked with increased 
photosystem I activity - directly resulting in higher ATP production rates.20,67,68 Additionally, the 
enzyme's reaction kinetics (in yeast) are not favourable for reversal of production formation.131 
While knockdown of the genes by the host is a possibility, this is not reported as a common 
occurrence in S. elongatus, unlike model eukaryotic algae such as Chlamydomonas reinhardtii 
which carry out RNA interference.132 
The second, and more likely, potential cause of no apparent reduction in mevalonate 
concentration is limited substrate availability within the cells. This low availability in the fed 
substrate assay may be due to very low efficiency of metabolite membrane permeability in S. 
elongatus. The annotated genome of S. elongatus lists the majority of transporters as being 
involved with metal ions, as well as the type II secretion system for peptides.123 Low membrane 
permeability has been previously demonstrated for small metabolites (lactate, fructose, glucose) 
in S. elongatus.48 (Contrary to the higher membrane permeability seen for the same weak acid 
{lactate} in Synechocystis.50) When the relevant transporter was transformed into S. elongatus, 
membrane permeability issues were eliminated for the metabolite. In the case of an added hexose 
sugar transporter, S. elongatus cells were even able to sustain heterotrophic growth in dark 
conditions. 
The addition of a transporter for mevalonate along with the lower MVA pathway would help 
to provide better insight into membrane permeability of heterologous metabolites in S. elongatus. 
Without the inclusion of a functional transporter, the use of radio-labelled mevalonate fed at 
much higher concentrations may be the most effective experimental option to probe this issue. 
Biofilm formation 
I attempted to reproduce a biofilm phenotype demonstrated in S. elongatus by Schatz et al, 
but was unsuccessful with my knockout strategy. I was most likely unable to fully segregate any 
transformants to a homo-polyploid state. Any remaining genome copies without the knockout 
would remain capable of secreting the presumed biofilm self-inhibitory small molecule/peptide. 
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Additionally, the authors had demonstrated the expression of two endogenous genes 
(Synpcc7942_1133 and Synpcc7942_1134) were necessary in addition to the knockout to 
generate the desired phenotype. While I did not validate protein expression for these genes in my 
strain, expression would be expected in the wild type stock unless a random inactivating 
mutation occurred in the original stock. 
I am currently unaware of any laboratories that have reproduced the results generated, but the 
experiments used to characterise the cause of the phenotype appear well controlled. As the 
publication did not specify the origin or age of their S. elongatus stock, the clearest additional 
validation experiment for the phenotype's cause may be a whole genome analysis against the 
current reference genome.  
Design-build-test cycles in S. elongatus 
In my attempt to add this model organism to the collection of those already in use in our 
laboratory, I experienced multiple challenges with technical procedures specific to S. elongatus. 
I initially experienced non-viable transformation efficiencies when using the common natural 
transformation method for S. elongatus. I was unable to determine the cause of the low 
efficiency and switched to using the more robust tri-parental mating method. While marginally 
more labour intensive, the gain in transformation efficiency was a necessity. While 
electroporation can be carried out in some cyanobacteria species (Synechocystis PCC6803, 
Nostoc PCC 7120,) it has not been demonstrated in Synechococcus elongatus PCC 7942.46 
Even with a robust transformation method, contamination of strains by environmental 
microbes was a recurring concern. Cultures could have no apparent contaminating growth at 
inoculation, but become unusable over their period of growth as additional carbon was fixed 
photosynthetically. The slow growth rate of S. elongatus made this problematic as the 
cyanobacteria were not able to multiply at a rate that would make contaminating heterotrophs a 
negligible issue. As done here, and in other laboratories, the most effective method to manage 
this challenge appears to be frequently spotting the cultures onto heterotrophic media to screen 
for heterotrophic contaminants.48  
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The need to maintain strains in liquid culture for ease of use likely aggravates this issue. 
When putative transformants are picked from solid media they are first transferred to a small 
volume starter culture (typically a 24-well plate) before passaging the viable cultures into larger 
volumes. The recovery of strains from frozen stocks requires a similarly lengthy process. 
The slow rate of growth also made attempting to separate out the desired strain from 
contaminating colonies on solid media highly challenging. In my experience, once the culture 
was identified as contaminated, heterotrophic colonies would form at a high enough rate on 
photoautotrophic solid media that the S. elongatus colonies could not be easily picked without 
carrying contaminating cells over. Attempting to mechanically separate the cell types by 
streaking proved similarly problematic. 
CRISPR-Cas facilitated engineering presents an interesting opportunity to speed up the 
engineering cycle in Synechococcus elongatus PCC 7942 and other polyploids with random 
genome segregation.133,134 S. elongatus has no known CRISPR-Cas system that could be 
repurposed for genome editing, making the addition of a heterologous construct necessary.135 
A 'clonal' population following a transformation protocol is Synechococcus elongatus PCC 
7942 can result in cells within the population having between 0-100% of their genomes 
containing the integration of interest. This mixed population can maintain itself in culture, or 
result in the complete gain or loss of the genome of interest following further culturing. To 
achieve a true clonal population, repeated sub-culturing can be required.  
Traditional integration tools for Synechococcus elongatus PCC 7942 rely on large homology 
regions for their efficiency.96 These regions are typically seen in practice ranging from 500-
1500bp. Targeted CRISPR-Cas cutting of the genome in regions expected to be ablated by an 
integration event could eliminate additional weeks sub-culturing and potentially reduce the 
required size of the homology regions for efficient transformations. Additionally, knockouts 
would be able to propagate immediately within a cell's multiple genomes from only a single copy 
of the required CRISPR-Cas guide RNAs. 
As also discussed by others, the two areas required for increased reliability in cyanobacterial 
engineering are better understood parts and more efficient tools. Much like with more unrelated 
species groups, inferences can not necessarily be made about part functionality in one 
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cyanobacterial species from data collected in another. Multiple review articles have attempted to 
compile part data sheets out of the existing literature, but little quantitative or context-normalised 
data is available still. While successful approaches to faster genome modification in S. elongatus 
will undoubtedly appear, the biggest hurdle to rapid engineering of model photoautotrophic 
cyanobacterial systems remains growth rate.  
I am hopeful that further characterisation of the fast growing Synechococcus elongatus 
UTEX 2973 species will result in its greater use as a host species for engineered systems, and 
that the better comprehension of its biology can be used to enhance our understanding of carbon 
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Supplementary Figure  1 
Non-commercial incubators used for S. elongatus plates. (A) Small plate incubator. 34°C set point maintained from 
heat output of bulbs. Maximum 50μmol∙m-2s-1 light output. (B) Converted anaerobic hood for plate incubation. 






Supplementary Table 1. List of primers used 




















Codon optimised HMGR-Sa sequence 
 
LOCUS       pZW(NS1:MTSa)        8211 bp ds-DNA     circular      
DEFINITION  . 
FEATURES             Location/Qualifiers 
     misc_recomb     744..1543 
                     /label="NS1 CDS" 
     CDS             1550..2694 
                     /label="SpecR cassette CDS" 
     misc_feature    2728..2757 
                     /label="lacProm primer" 
     misc_recomb     7431..8210 
                     /label="NS1 CDS" 
     CDS             2956..4137 
                     /label="atoB CDS" 
     CDS             5646..6926 
                     /label="HMGR-Sa (codon optimised Staphylococcus aureus origin)" 
     misc_feature    7332..7359 
                     /label="rrnB T2 terminator primer" 
     CDS             4154..5626 
                     /label="ERG13 CDS" 
ORIGIN 
        1 gataatctca tgaccaaaat cccttaacgt gagttttcgt tccactgagc gtcagacccc 
       61 gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 
      121 caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 
      181 ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt tcttctagtg 
      241 tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 
      301 ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 
      361 tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 
      421 cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 
      481 gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 
      541 ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 
      601 gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 
      661 agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 
      721 tttgctcaca tgtgtgctgg gccccaatgc cttctccaag ggcggcattc ccctgactgt 
      781 tgaaggcgtt gccaatatca agattgctgg ggaagaaccg accatccaca acgcgatcga 
      841 gcggctgctt ggcaaaaacc gtaaggaaat cgagcaaatt gccaaggaga ccctcgaagg 
      901 caacttgcgt ggtgttttag ccagcctcac gccggagcag atcaacgagg acaaaattgc 
      961 ctttgccaaa agtctgctgg aagaggcgga ggatgacctt gagcagctgg gtcaagtcct 
     1021 cgatacgctg caagtccaga acatttccga tgaggtcggt tatctctcgg ctagtggacg 
     1081 caagcagcgg gctgatctgc agcgagatgc ccgaattgct gaagccgatg cccaggctgc 
     1141 ctctgcgatc caaacggccg aaaatgacaa gatcacggcc ctgcgtcgga tcgatcgcga 
     1201 tgtagcgatc gcccaagccg aggccgagcg ccggattcag gatgcgttga cgcggcgcga 
     1261 agcggtggtg gccgaagctg aagcggacat tgctaccgaa gtcgctcgta gccaagcaga 
     1321 actccctgtg cagcaggagc ggatcaaaca ggtgcagcag caacttcaag ccgatgtgat 
     1381 cgccccagct gaggcagctt gtaaacgggc gatcgcggaa gcgcgggggg ccgccgcccg 
     1441 tatcgtcgaa gatggaaaag ctcaagcgga agggacccaa cggctggcgg aggcttggca 
     1501 gaccgctggt gctaatgccc gcgacatctt cctgctccag aagtctagac cagccaggac 
     1561 agaaatgcct cgacttcgct gctacccaag gttgccgggt gacgcacacc gtggaaacgg 
     1621 atgaaggcac gaacccagtg gacataagcc tgttcggttc gtaagctgta atgcaagtag 
     1681 cgtatgcgct cacgcaactg gtccagaacc ttgaccgaac gcagcggtgg taacggcgca 
     1741 gtggcggttt tcatggcttg ttatgactgt ttttttgggg tacagtctat gcctcgggca 
     1801 tccaagcagc aagcgcgtta cgccgtgggt cgatgtttga tgttatggag cagcaacgat 
     1861 gttacgcagc agggcagtcg ccctaaaaca aagttaaaca ttatgaggga agcggtgatc 
     1921 gccgaagtat cgactcaact atcagaggta gttggcgtca tcgagcgcca tctcgaaccg 
     1981 acgttgctgg ccgtacattt gtacggctcc gcagtggatg gcggcctgaa gccacacagt 
     2041 gatattgatt tgctggttac ggtgaccgta aggcttgatg aaacaacgcg gcgagctttg 
     2101 atcaacgacc ttttggaaac ttcggcttcc cctggagaga gcgagattct ccgcgctgta 
     2161 gaagtcacca ttgttgtgca cgacgacatc attccgtggc gttatccagc taagcgcgaa 
     2221 ctgcaatttg gagaatggca gcgcaatgac attcttgctg gtatcttcga gccagccacg 
     2281 atcgacattg atctggctat cttgctgaca aaagcaagag aacatagcgt tgccttggta 
     2341 ggtccagcgg cggaggaact ctttgatccg gttcctgaac aggatctatt tgaggcgcta 
     2401 aatgaaacct taacgctatg gaactcgccg cccgactggg ctggcgatga gcgaaatgta 
     2461 gtgcttacgt tgtcccgcat ttggtacagc gcagtaaccg gcaaaatcgc gccgaaggat 
     2521 gtcgctgccg actgggcaat ggagcgcctg ccggcccagt atcagcccgt catacttgaa 
     2581 gctagacagg cttatcttgg acaagaagaa gatcgcttgg cctcgcgcgc agatcagttg 
     2641 gaagaatttg tccactacgt gaaaggcgag atcaccaagg tagtcggcaa ataacccatg 
     2701 catgctcact cattaggcac cccaggcttt acactttatg cttccggctc gtatgttgtg 
     2761 tggaattgtg agcggataac aatttcacac aggaaacagc tatgaccatg attacgccaa 
     2821 gcgcgcaatt aaccctcact aaagggaaca aaagctgggt accgggcccc ccctcgaggt 
     2881 cgacggtatc gataagcttg atatcgaatt cctgcagccc ggggatcctc tagagtcgac 
     2941 taggaggaat ataaaatgaa aaattgtgtc atcgtcagtg cggtacgtac tgctatcggt 
     3001 agttttaacg gttcactcgc ttccaccagc gccatcgacc tgggggcgac agtaattaaa 
     3061 gccgccattg aacgtgcaaa aatcgattca caacacgttg atgaagtgat tatgggtaac 
     3121 gtgttacaag ccgggctggg gcaaaatccg gcgcgtcagg cactgttaaa aagcgggctg 
     3181 gcagaaacgg tgtgcggatt cacggtcaat aaagtatgtg gttcgggtct taaaagtgtg 
     3241 gcgcttgccg cccaggccat tcaggcaggt caggcgcaga gcattgtggc ggggggtatg 
     3301 gaaaatatga gtttagcccc ctacttactc gatgcaaaag cacgctctgg ttatcgtctt 
     3361 ggagacggac aggtttatga cgtaatcctg cgcgatggcc tgatgtgcgc cacccatggt 
     3421 tatcatatgg ggattaccgc cgaaaacgtg gctaaagagt acggaattac ccgtgaaatg 
     3481 caggatgaac tggcgctaca ttcacagcgt aaagcggcag ccgcaattga gtccggtgct 
     3541 tttacagccg aaatcgtccc ggtaaatgtt gtcactcgaa agaaaacctt cgtcttcagt 
     3601 caagacgaat tcccgaaagc gaattcaacg gctgaagcgt taggtgcatt gcgcccggcc 
     3661 ttcgataaag caggaacagt caccgctggg aacgcgtctg gtattaacga cggtgctgcc 
     3721 gctctggtga ttatggaaga atctgcggcg ctggcagcag gccttacccc cctggctcgc 
     3781 attaaaagtt atgccagcgg tggcgtgccc cccgcattga tgggtatggg gccagtacct 
     3841 gccacgcaaa aagcgttaca actggcgggg ctgcaactgg cggatattga tctcattgag 
     3901 gctaatgaag catttgctgc acagttcctt gccgttggga aaaacctggg ctttgattct 
     3961 gagaaagtga atgtcaacgg cggggccatc gcgctcgggc atcctatcgg tgccagtggt 
     4021 gctcgtattc tggtcacact attacatgcc atgcaggcac gcgataaaac gctggggctg 
     4081 gcaacactgt gcattggcgg cggtcaggga attgcgatgg tgattgaacg gttgaattaa 
     4141 ggaggacagc taaatgaaac tctcaactaa actttgttgg tgtggtatta aaggaagact 
     4201 taggccgcaa aagcaacaac aattacacaa tacaaacttg caaatgactg aactaaaaaa 
     4261 acaaaagacc gctgaacaaa aaaccagacc tcaaaatgtc ggtattaaag gtatccaaat 
     4321 ttacatccca actcaatgtg tcaaccaatc tgagctagag aaatttgatg gcgtttctca 
     4381 aggtaaatac acaattggtc tgggccaaac caacatgtct tttgtcaatg acagagaaga 
     4441 tatctactcg atgtccctaa ctgttttgtc taagttgatc aagagttaca acatcgacac 
     4501 caacaaaatt ggtagattag aagtcggtac tgaaactctg attgacaagt ccaagtctgt 
     4561 caagtctgtc ttgatgcaat tgtttggtga aaacactgac gtcgaaggta ttgacacgct 
     4621 taatgcctgt tacggtggta ccaacgcgtt gttcaactct ttgaactgga ttgaatctaa 
     4681 cgcatgggat ggtagagacg ccattgtagt ttgcggtgat attgccatct acgataaggg 
     4741 tgccgcaaga ccaaccggtg gtgccggtac tgttgctatg tggatcggtc ctgatgctcc 
     4801 aattgtattt gactctgtaa gagcttctta catggaacac gcctacgatt tttacaagcc 
     4861 agatttcacc agcgaatatc cttacgtcga tggtcatttt tcattaactt gttacgtcaa 
     4921 ggctcttgat caagtttaca agagttattc caagaaggct atttctaaag ggttggttag 
     4981 cgatcccgct ggttcggatg ctttgaacgt tttgaaatat ttcgactaca acgttttcca 
     5041 tgttccaacc tgtaaattgg tcacaaaatc atacggtaga ttactatata acgatttcag 
     5101 agccaatcct caattgttcc cagaagttga cgccgaatta gctactcgcg attatgacga 
     5161 atctttaacc gataagaaca ttgaaaaaac ttttgttaat gttgctaagc cattccacaa 
     5221 agagagagtt gcccaatctt tgattgttcc aacaaacaca ggtaacatgt acaccgcatc 
     5281 tgtttatgcc gcctttgcat ctctattaaa ctatgttgga tctgacgact tacaaggcaa 
     5341 gcgtgttggt ttattttctt acggttccgg tttagctgca tctctatatt cttgcaaaat 
     5401 tgttggtgac gtccaacata ttatcaagga attagatatt actaacaaat tagccaagag 
     5461 aatcaccgaa actccaaagg attacgaagc tgccatcgaa ttgagagaaa atgcccattt 
     5521 gaagaagaac ttcaaacctc aaggttccat tgagcatttg caaagtggtg tttactactt 
     5581 gaccaacatc gatgacaaat ttagaagatc ttacgatgtt aaaaaataaa ttcaggaaac 
     5641 agaccatgtc catgcaaagt ttagataaga attttcgaca tttatctcgt aaagaaaagt 
     5701 tacaacaatt ggttgataag caatggttat cagaagaaca attcgacatt ttactgaatc 
     5761 atccattaat cgatgaagaa gtagccaata gtttaattga aaatgtcatc gcgcaaggtg 
     5821 cattacccgt tggattatta ccgaatatca ttgtggacga taaggcatat gttgtaccta 
     5881 tgatggtgga agagccttca gttgtcgctg cagctagtta tggtgcaaag ctagtgaatc 
     5941 agactggcgg atttaaaacg gtatcttctg aacgtattat gataggtcaa atcgtctttg 
     6001 atggcgttga cgatactgaa aaattatcag cagacattaa agctttagaa aagcaaattc 
     6061 ataaaattgc ggatgaggca tatccttcta ttaaagcgcg tggtggtggt taccaacgta 
     6121 tagcgattga tacatttcct gagcaacagt tactatcttt aaaagtattt gttgatacga 
     6181 aagatgctat gggcgctaat atgcttaata cgattttaga ggccataact gcatttttaa 
     6241 aaaatgaatt tccgcaaagc gacattttaa tgagtatttt atccaatcat gcaacagcgt 
     6301 ccgttgttaa agttcaaggc gaaattgatg ttaaagattt agcaaggggc gagagaactg 
     6361 gagaagaggt tgccaaacga atggaacgtg cttctgtatt ggcccaagta gatattcatc 
     6421 gtgcagcaac acataataaa ggtgttatga atggcataca tgctgttgtt ttagcaacag 
     6481 gaaatgatac gcgtggtgca gaagcaagtg cgcatgcata cgcgagtcgt gacggacagt 
     6541 atcgtggtat tgctacatgg cgttacgatc aagatcgtca acgattgatt ggtacaattg 
     6601 aagtgcctat gacattggca atcgttggcg gtggtacaaa agtattacca attgctaaag 
     6661 cttcattaga gctactaaat gtagagtcag cacaagaatt aggtcatgta gttgctgccg 
     6721 ttggtttagc gcaaaacttt gcagcatgtc gcgcgcttgt gtcagaaggt attcaacaag 
     6781 gtcatatgag tttacaatat aaatcattag ctatcgttgt aggggcaaaa ggtgatgaaa 
     6841 ttgctaaagt agctgaagct ttgaaaaaag aaccccgtgc aaatacacaa gcagcggaac 
     6901 atattttaca agaaattaga caacaataat tacctgcagg catgcaagct tggctgtttt 
     6961 ggcggatgag agaagatttt cagcctgata cagattaaat cagaacgcag aagcggtctg 
     7021 ataaaacaga atttgcctgg cggcagtagc gcggtggtcc cacctgaccc catgccgaac 
     7081 tcagaagtga aacgccgtag cgccgatggt agtgtggggt ctccccatgc gagagtaggg 
     7141 aactgccagg catcaaataa aacgaaaggc tcagtcgaaa gactgggcct ttcgttttat 
     7201 ctgttgtttg tcggtgaacg ctctcctgag taggacaaat ccgccgggag cggatttgaa 
     7261 cgttgcgaag caacggcccg gagggtggcg ggcaggacgc ccgccataaa ctgccaggca 
     7321 tcaaattaag cagaaggcca tcctgacgga tggccttttt gcgtttctac aaactctttt 
     7381 gtttattttt ctaaatacat tcaaatatgt atccgctcat gacctaggtc tcgagtccct 
     7441 gctcgtcacg ctttcaggca ccgtgccaga tatcgacgtg gagtcgatca ctgtgattgg 
     7501 cgaaggggaa ggcagcgcta cccaaatcgc tagcttgctg gagaagctga aacaaaccac 
     7561 gggcattgat ctggcgaaat ccctaccggg tcaatccgac tcgcccgctg cgaagtccta 
     7621 agagatagcg atgtgaccgc gatcgcttgt caagaatccc agtgatcccg aaccatagga 
     7681 aggcaagctc aatgcttgcc tcgtcttgag gactatctag atgtctgtgg aacgcacatt 
     7741 tattgccatc aagcccgatg gcgttcagcg gggtttggtc ggtacgatca tcggccgctt 
     7801 tgagcaaaaa ggcttcaaac tggtgggcct aaagcagctg aagcccagtc gcgagctggc 
     7861 cgaacagcac tatgctgtcc accgcgagcg ccccttcttc aatggcctcg tcgagttcat 
     7921 cacctctggg ccgatcgtgg cgatcgtctt ggaaggcgaa ggcgttgtgg cggctgctcg 
     7981 caagttgatc ggcgctacca atccgctgac ggcagaaccg ggcaccatcc gtggtgattt 
     8041 tggtgtcaat attggccgca acatcatcca tggctcggat gcaatcgaaa cagcacaaca 
     8101 ggaaattgct ctctggttta gcccagcaga gctaagtgat tggaccccca cgattcaacc 
     8161 ctggctgtac gaataaggtc tgcattcctt cagagagaca ttgccatgcc g 
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